16th ASIA-PACIFIC CONGRESS

OF CLINICAL BIOCHEMISTRY

June 26-30, 2022

 1

CONTENTS

Welcome letters 2

Committees 5

Executive Boards 6

Week Agenda 10

Scientific Programme 13

Closed Meetings 48

Speakers and Chairs 50

Satellite Meeting 52

Registration 53

Congress Venue 54

General information 56

Congress Secretariat 57

Sponsors 58

Exhibitors 67

Exhibition Area map 74

Exhibitors List 75

DOWNLOAD WORLDLAB APP

Using the WORLDLAB App you can display the following:
Scientific programme with speakers’ presentations
Posters
General information
Sponsors and exhibitors
Push notifications with the latest news
Breaking news

Sponsored by
2

IFCC WELCOME MESSAGE

Dear Friends and Colleagues,

it is my great pleasure to present this welcoming message to all national and international conference
participants, corporate sponsors, exhibitors and IFCC officers from around the world. The IFCC
WorldLab Congress presents a unique opportunity to bring together laboratory medicine experts and
industry partners from all regions of the world to discuss the latest advances in clinical laboratory
science and diagnostics technology. I would like to personally invite each one of you to attend the
2022 WorldLab Congress in the beautiful and vibrant city of Seoul. The conference is being held in
the Asia-Pacific region which is witnessing the highest rates of economical and technological growth
around the world in many areas including in vitro diagnostics. It’s an exciting and fast evolving time
for the field of clinical chemistry and laboratory medicine and this conference would be an excellent
opportunity to present and discuss the latest advances in clinical laboratory diagnostics and meet
colleagues from around the world. It is also a very opportune time to be holding this international forum
to highlight the very important role of laboratory medicine in healthcare delivery including the global
fight against public health threats such as the current coronavirus pandemic. What is becoming very
clear during this crisis is that clinical laboratory operations have been critical in the global response to
this unprecedented pandemic through rapid diagnosis of viral infection, serological monitoring of the
affected populations, and biochemical monitoring of hospitalized patients with more severe COVID-19
induced complications. The WorldLab congress is an excellent opportunity to bring together experts
in various fields of laboratory diagnostics to discuss the major advances in molecular, serological,
biochemical, and hematological assessment of patients with coronavirus infection as well as other
infectious diseases. Special sessions are being planned to discuss and highlight the critical and central
role of the clinical laboratory in population screening and public health measures at national and
international levels.

The IFCC organization is pleased to partner with the Korean Society of Clinical Chemistry and Asia-
Pacific Federation of Clinical Biochemistry to hold this important international event, assembling
laboratory scientists and IVD industry leaders from IFCC regional federations and member countries
around the globe. I very much look forward to meeting many of you and discussing the opportunities
and challenges for laboratory medicine over the coming decade. the future holds considerable promise
for the field of laboratory diagnostics and its umbrella organizations such as IFCC. As IFCC continues
to grow and expand its international reach, we remain committed to the key goal of advancing better
healthcare worldwide through high quality laboratory diagnostics.

After two years of lockdowns and travel restrictions in almost all regions across the world, I am certain
that most of you are very eager to get together again in an international forum. The 2022 WorldLab
provides an excellent and timely opportunity to do just that. Looking forward to seeing many of you in
Seoul, a city that not only has a very rich and ancient history and culture, it is also now ranked as an
alpha world city with the world’s 4th largest metropolitan economy!

Khosrow Adeli PhD, FCACB,

DABCC, FAACC
IFCC President (2020-2023)
 3

APFCB WELCOME MESSAGE

Dear Participants of the 2022 Worldlab & APFCB Congress,

it is with great pleasure that I welcome you all to this Worldlab 2022.
After having more than two years of only remote meetings and conferences, this congress celebrates
not only the collaboration of the three organisations, IFCC, APFCB and KSCC, for the first time in
history, but also the first time we are able to physically gather again in-person, embracing a new
normal where handshakings and warm hugs are possible, and yet strong control of transmission is
being practiced.

Laboratory professionals around the globe have learned a lot during the pandemic. Never before in
history has the laboratory been in such a critical position, playing an essential role in the fight against
the deadly Covid-19. Many experiences will be shared during this conference. I hope all participants
will enjoy the scientific programs, and go home more motivated to practise the best of knowledge
learned during the conference.

I take this opportunity to thank the IFCC for it’s strong support, to make this congress possible. We
also thank KSCC for the commitment and hard work for organising a completely new business model
of conducting conferences in this transition period. We are aware that it has not been easy for coming
to the best decisions in such an uncertain and ever-changing situation we faced. But with strong
commitments, and with grateful hearts that the pandemic is now coming to a lowest-ever level, we are
able to make it all come true. We certainly thank all the participants, attending in-person as well as
virtually, because you all will be the indicator of the success of this congress.

I wish you all a productive and enjoyable week ahead.

Prof Dr Sunil Sethi

APFCB President
4

KSCC WELCOME MESSAGE

Dear Colleagues and Friends,

it is with great delight that we welcome you to the 24th International Congress of Clinical Chemistry
and Laboratory Medicine & 16th Asia-Pacific Congress of Clinical Biochemistry at Coex, Seoul, Korea
from June 26 to 30, 2022.
Also, we are pleased to announce that this Congress in Seoul will be held jointly with the 16th APFCB
(Asia-Pacific Federation of Clinical Biochemistry) Congress in June 2022. The IFCC and APFCB have
agreed that a joint conference would be more attractive and beneficial for both conference delegates
and corporate sponsors and will ensure wider participation from laboratory professionals and industry
partners across Asia-Pacific and around the world.
Since the first IFCC congress in 1954, the main goal of the conference has been the globalization of
medical knowledge related to Clinical Chemistry and Laboratory Medicine through a well-structured
system of continuing education. As originally planned, we do our best to provide you with the exciting
and informative symposium program including plenary lectures, educational workshops, satellite
meetings and poster sessions.
COVID-19 has faced many challenges, but the world is working together to overcome this global
disaster. Always hoping that everything will get back on track like it used to be as soon as possible, we
are confident that this Joint Congress 2022 will be a rewarding and unforgettable experience for all our
participants attending from around the world.

We look forward to meeting you at the 24th IFCC WorldLab & 16th APFCB in June 2022.
Yours truly,

Won-Ki Min M.D.,Ph.D. Junghan Song M.D.,Ph.D.

Congress President, Congress Organizing Committee Chair
IFCC WorldLab Seoul 2022 IFCC WorldLab Seoul 2022

Sail Chun M.D.,Ph.D. Jehoon Lee M.D.,Ph.D.

Scientific Programme President,
Committee Chair, Korean Society of Clinical
IFCC WorldLab Seoul 2022 Chemistry
 5

COMMITTEES INTERNATIONAL SCIENTIFIC

ADVISORY BOARD

Anyla Kasneci Bulo (Albania)

Peter Ward (Australasia)
Andrea Griesmacher (Austria)
CONGRESS PRESIDENT Joris Delanghe (Belgium)
Álvaro Justiniano Grosz (Bolivia)
Prof. Won-Ki Min Eduardo Aranda (Chile)
Baishen Pan (P.R. China)
Chuanxin Wang (P.R. China)
CONGRESS ORGANIZING COMMITTEE Hong Shang (P. R. China)
Andreas Rothstein (Colombia)
Prof. Junghan Song, Organizing Committee Chair Jasna Lenicek Krleza (Croatia)
Prof. Yeo-Min Yun, Secretary General Tomáš Zima (Czech Republic)
Prof. Sail Chun, Scientific Programme Chair Mohamed Shaarawy (Egypt)
Prof. Jehoon Lee, President of KSCC (1) Kalle Kisand (Estonia)
Prof. Sang Hoon Song, Secretary of KSLM (2) Paivi Laitinen (Finland)
Prof. Sunil Sethi, IFCC Executive Board Philippe Gillery (France)
Dr. Douglas Chung, IFCC Corporate Member Michael Vogeser (Germany)
Zsuzsa Bagoly (Hungary)
Prof. Helen Martin, IFCC C-CC
Jon J. Jonsson (Iceland)
Dr. Stefano Montalbetti, MZ Events, PCO
Rajiv R. Sinha (India)
July Kumalawati (Indonesia)
(1) Korean Society of Clinical Chemistry
Graham Lee (Ireland)
(2) Korean Society for Laboratory Medicine
Marielle Kaplan (Israel)
Giuseppe Lippi (Italy)
Masato Maekawa (Japan)
SCIENTIFIC PROGRAM COMMITTEE Yousif Y. Bilto (Jordan)
Hyojin Chae (Korea)
Sail Chun (Korea), Chair Jae-Woo Chung (Korea)
Sung-Eun Cho (Korea) Minje Han (Korea)
Robert L. Fitzgerald (USA) Tae-Dong Jeong (Korea)
Philippe Gillery (France) Misuk Ji (Korea)
Daniel T. Holmes (Canada) Sollip Kim (Korea)
Graham Jones (Australia) Kyunghoon Lee (Korea)
Soo-Youn Lee (Korea) Sang-Guk Lee (Korea)
Yong Wha Lee (Korea) Jinsook Lim (Korea)
Woochang Lee (Korea) Hyung-Doo Park (Korea)
Masato Maekawa (Japan) Dalius Vitkus (Lithuania)
Nader Rifai (USA) Katerina Tosheska Trajkovska (Macedonia)
Namhee Ryoo (Korea) Leslie Lai (Malaysia)
José Francisco Muñoz-Valle (Mexico)
Cheng-Bin Wang (P.R. China)
Gligorovic-Barhanovic Najdana (Montenegro)
Chabraoui Layachi (Morocco)
Lena Jafri (Pakistan)
Juan Castillo Mewa (Panama)
Ortellado-Canese Juana (Paraguay)
Ronaldo E. Puno (Philippines)
Grazyna Sypniewska (Poland)
Brudasca Ioana (Romania)
Anwar Borai (Saudi Arabia)
Zorica Sumarac (Serbia)
Oliver Rácz (Slovak Republic)
Evgenija Homšak (Slovenia)
Tahir Pillay (South Africa)
Buño Antonio (Spain)
Imad Fadl Elmula (Sudan)
Per Bjellerup (Sweden)
Rossier Michel F (Switzerland)
Adnan Alkhatib (Syrian Arab Republic)
Robert de Jonge (The Netherland)
Yucel Dogan (Turkey)
Carmen L. Wiley (USA)
Laura Yametti (Uruguay)
Tran Huu Tam (Vietnam)
IFCC EXECUTIVE BOARD KOREAN ADVISORY BOARD

Khosrow Adeli, President Jeong-Ho Kim, Past President

David Kinniburgh, Secretary Gye Cheol Kwon, Past President
Alexander Haliassos, Treasurer Hi Jeong Kwon, Auditor
Joseph Passarelli, Corporate Representative Kyung Dong Kim, Past President
Abderrazek Hedhili, Arab Federation of Clinical Biology Dal Sik Kim, Past Board Member
(AFCB) Jeong-Man Kim, Past Board Member
Adekunle B Okesina, African Federation of Clinical Dae Soo Moon, Past Board Member
Chemistry (AFCC) Ile-Kyu Park, Past Board Member
Endang Hoyaranda, Asia-Pacific Federation for Clinical Soon-Pal Suh, Past President
Biochemistry and Laboratory Medicine (APFCB) Kyung-Eun Song, Auditor
Ana Maria Lena Rodríguez, Latin-American Wee Gyo Lee, Past Board Member
Confederation of Clinical Biochemistry (COLABIOCLI) Eun-Hee Lee, Past Board Member
Tomris Ozben, European Federation of Clinical
Chemistry and Laboratory Medicine (EFLM)
Stephen Hill, North American Federation of Clinical KSCC EXECUTIVE BOARD
Chemistry and Laboratory Medicine (NAFCC)
Matthew McQueen, Past President Jehoon Lee, President
Mathias M. Müller, Past President Hyung-Doo Park, Secretary General
Jocelyn Hicks, Past President Sung-Eun Cho, Treasurer
Graham Beastall, Past President Sollip Kim, Scientific Affairs
Maurizio Ferrari, Past President Pil Whan Park, Editor
Yong Wha Lee, Director of Education
Minje Han, Director of Legal Affairs
APFCB EXECUTIVE BOARD Hyojin Chae, Director of Publication
Sun Young Cho, Director of Public Relations
Sunhil Sethi, President Jae-Woo Chung, Director of International Affairs
Leslie C. Lai, Immediate Past President Yeo-Min Yun, Director of Standardization and Harmonization
Endang Hoyaranda, Vice-President Sang Gon Lee, Director of Health Insurance Affairs
Helen Martin, Secretary Sang Hoon Song, Director of Mass Spectrometry Application
Leila Florento, Treasurer Hwan Sub Lim, Director of Strategic Plan
Alexander Wong, Corporate Representative Yeongsic Kim, Director of Member Management
Yeo-Min Yun, Director of IFCC Relation
Woochang Lee, Director of IVD
 7

IFCC DISTINGUISHED AWARDS

THE IFCC IS PLEASED TO ANNOUNCE THE WINNERS OF THE TEN 2020
IFCC DISTINGUISHED AWARDS.

The IFCC Distinguished Awards are bestowed to laboratory medicine

professionals to recognize their outstanding achievements, publicize their
exceptional research and contributions to medicine and healthcare, and
encourage the overall advancement of clinical chemistry and laboratory
medicine.

Prof. Nader RIFAI (United States)

IFCC-Howard Morris Distinguished Clinical Chemist Award, sponsored by
Yashraj Biotechnology Ltd.

Dr Ghassan SHANNAN (Syria)

IFCC Henry Wishinsky Award for Distinguished International Services,
sponsored by Siemens.

Dr Thomas ANNESLEY (United States)

IFCC Award for Distinguished Contributions in Education, sponsored by Abbott
Diagnostics.

Dr Andrea FERREIRA-GONZALEZ (United States)

IFCC Award for Significant Contributions in Molecular Diagnostics, sponsored by
Abbott Molecular.

Dr David B. SACKS (United States)

IFCC Distinguished Award for Laboratory Medicine and Patient Care, sponsored
by Sekisui Diagnostics.

Dr Gary L. MYERS (United States)

IFCC-Robert Schaffer Award for Outstanding Achievements in the Development
of Standards for Use in Laboratory Medicine, co-sponsored by NIST and CLSI.

Dr Fred S. APPLE (United States)

IFCC Distinguished Award for Contributions to Cardiovascular Diagnostics,
sponsored by HyTest.

Dr Jean Baptiste WOILLARD (France)

IFCC-Gérard Siest Young Scientist Award for Distinguished Contributions in
Pharmacogenetics, sponsored by Biologie Prospective.

Dr Sandra QUIJANO (Colombia)

IFCC Distinguished Women Scientist Award For Contribution To In Vitro
Diagnostics, sponsored by Yashraj Biotechnology Ltd.

Dr Livia S. EBERLIN (United States)

IFCC Young Investigator Award, sponsored by IFCC.
8

IFCC ROCHE TRAVEL SCHOLARSHIPS

The IFCC is proud to announce the recipients of the IFCC-Roche Travel Scholarships

Tegared Henok Andualem (Ethiopia)

Antigoni Poulopoulou (Greece)
I Putu Yuda Prabawa (Indonesia)
Rima Hayyu Chrisnanda (Indonesia)
Yunika Puspa Dewi (Indonesia)
Amita Yadav (India)
Prasad Naidu Mundllamudi (India)
Taru Goyal (India)
Kiran Venkata Satya Naga Kumar Pilla (India)
Agness Lakudzala (Malawi)
Bako Hauwa (Nigeria)
Njoku Chidiadi Maryann Atuegbu (Nigeria)
Obianyido Ozioma Ebere (Nigeria)
Oby Onyemailoh Obiageli Bridget (Nigeria)
Apeksha Niraula (Nepal)
Rakesh Pokhrel (Nepal)
Uttam Budhathoki (Nepal)
Othaniel Philip R. Balisan (Philippines)
Jamilah Campos Baragona (Philippines)
Rizana Kausar (Pakistan)
Siraj Muner (Pakistan)
Mohammed I. K. Alhaddad (Palestine)
Gawri Prabhashika Nandasena Abeynayake (Sri Lanka)

APFCB AWARDS
The Education and Laboratory Management Committee of the APFCB is proud to announce the
APFCB Young Scientist Awards.

The successful awardees are the following:

Fauqa Arinil Aulia - Indonesia

Victoria Indah Mayasari - Indonesia
Sushant Pokhrel - Nepal
Julie Sherfan - Australia
L Malavika - India
Shruti Gupta - India
Prasenjit Mitra - India
Smriti Suri - India
Kay Weng Choy - Australia
P. Padmavathi - India
Saswati Das - India
Mark Raymund G. Nava - Philippines
10

WEEK AGENDA
SUNDAY 26 JUNE
17:30-19:30 OPENING CEREMONY
19:30-21:30 WELCOME COCKTAIL

MONDAY 27 JUNE
10:00-17:30 EXHIBITION OPEN

AUDITORIUM ROOM 103 ROOM 101 ROOM 102 ROOM 104 ROOM 105

09:00-11:00 SYM1 SYM2 SYM3 SYM4 SYM5 IFCC SYM1

Applications of Best laboratory Value added To know each other in Current status A new era in medical
data science to the practices for kidney laboratory medicine of mass spectrometry of accreditation laboratory diagnostics
improvement of disease Point-of-Care Testing activities in laboratory management:
laboratory practice (POCT) medicine: do we application of
need it to become advanced mobile &
obligatory? web technology
11:00-11:45 BREAK
11:45-12:30 PL 1
Maximizing the
value of laboratory
medicine in Korea
12:30-13:00 POSTER / LUNCH
13:00-14:00 LW 1 LW 2 LW4 Korean Student
Roche Binding Site Siemens Healthineers Session
12.00-14.00
The golden age of Workflow solutions for Utilizing High-
the clinical lab as we the management of sensitivity Cardiac
transition from volume monoclonal gammo- Troponin Assays
to value - Clinical Lab pathies and primary for Improved
2.0 Movement immunodeficiencies Early Diagnostics:
13.00-14.00 – Freelite®, Hevylite® Laboratory Medicine
and igg subclasses and Clinical Practice
13.00-14.00 Guidelines
13.00-14.00
14:30-15:30 IFCC SYM 2 EDUW2 EDUW5 EDUW8 EDUW11 EDUW13
Using big data for Roche Snibe Diagnostic GC Labs Siemens Healthineers Beckman Coulter
improving healthcare
15:00-17:00 Cardiac Biomarkers: Thyroid Assays: Diagnostics and Serum free light Intelligent automation
The Key to Early Where do We Stand? testing landscape chains assays: for all: advanced
Intervention 14.30-15.30 beyond Covid-19: analytical and clinical intelligent automation
14.30-15.30 Dynamics of an performance on can help labs of
evolving market different analyzers all sizes improve
14.30-15.30 14.30-15.30 workflow, sample
turnaround time (tat)
and healthcare delivery
14.30-15.30
16:00-17:00 EDUW3 EDUW9 EDUW12 EDUW14
Seegene GC Genome Arkray Ortho Clinical
Diagnostics
Response of Seegene AI-based Liquid HbA1c in the monitoring,
medical foundation on Biopsy Test. diagnosis and screening In-vitro diagnostics
Covid-19 pandemic of diabetes: views on in acute and critical
16.00-17.00 AI-based Non-invasive quality requirements care – make the right
prenatal Test (NIPT). in relation to its clinical decisions for your most
use. important patients and
Association of gut drive improved clinical
microbiome and Analytical Performance and health economic
hypertension Evaluation of the Arkray outcomes with
16.00-17.00 ADAMS HA-8190V diagnostics.
HbA1c Analyzer
15.30-16.30 Novel HbA1c
enzymatic microslide
dry chemistry assay
15:30-16:30
17:30-18:30 SYM6 SYM7
State of the art; Issues on method
proficiency testing evaluation
16:30-18:30 16:30-18:30
 11

10:00-17:30 EXHIBITION OPEN

TUESDAY 28 JUNE
AUDITORIUM ROOM 103 ROOM 101 ROOM 102 ROOM 104 ROOM 105

09:00-11:00 SYM8 SYM9 SYM10 SYM11 SYM12 IFCC SYM3

Applying evidence- Implementation of Ethical issues in Future application of The role of The future of
based guidelines pharmacogenomics laboratory medicine automation in clinical laboratory in the standardization in
to increase clinical in the clinic laboratory management of laboratory medicine:
effectiveness in sepsis challenges and
laboratory medicine opportunities
11:00-11:45 BREAK
11:45-12:30 PL 2
Pharmacogenomics:
from discovery to
clinic
12:30-13:00 POSTER / LUNCH
13:00-14:00 LW 6 LW 7 LW 8 LW 9 Korean Student
Thermo Fisher Abbott GC MS Sysmex Session
Scientific 12.00-14.00
Total laboratory The nature of Smart Hematology
Cascadion™: Unlock solution helping DNA polymerase and Sepsis with
the power of LC-MS/ labs to achieve makes the difference Sysmex Laboratory
MS in your clinical operational of Liquid biopsy. Solutions.
lab excellence 13.00-14.00
13.00-14.00 13.00-14.00 New PETIA for
Procalcitonin –
Routine experience
and lessons learned
from EQA evaluation
13.00-14.00
14:30-15:30 IFCC SYM 4 EDUW16 EDUW19 EDUW22 EDUW25 EDUW27
Emerging Roche Beckman Coulter Siemens Sebia SCL
technologies: new Healthineers
trends and Clinical Improvement Monocyte distribution New opportunities Clinical laboratory
applications Insights from Clinical width, new cellular The value of ELF to measure HbA1c application of mass
15:00-17:00 Lab Benchmarking biomarker test in the screening by capillary spectrometry
Survey 14.30-15.30 and management of electrophoresis 14.30-15.30
14.30-15.30 non-alcoholic fatty 14.30-15.30
liver disease
14.30-15.30
16:00-17:00 EDUW17 EDUW28
Snibe Diagnostic A&T Corporation

Total & Free- Introduction of

Testosterone Green Cross
Assays in Support Laboratories &
of Diagnosis of Total Laboratory
Hypogonadism and Automation System
Fertility 15:30-16:30

The molecision
sars-cov-2 rt-pcr and
the rapisafe antigen
test in fighting the
pandemic
16.00-17.00
17:30-18:30 EDUW21 SYM13 SYM14
Handok The microbiome: Therapeutic
Present and future drug monitoring:
Targeted omics challenges in Technical and
for clinical and laboratory medicine clinical experience
translational 16:30-18:30 16:30-18:30
research
17.30-18.30

PL = PLENARY LECTURE
SYM = SYMPOSIUM
EDUW = EDUCATIONAL WORKSHOP (SPONSORED BY INDUSTRY)
LW = LUNCH WORKSHOP (SPONSORED BY INDUSTRY)
12

WEDNESDAY 29 JUNE
10:00-17:30 EXHIBITION OPEN

AUDITORIUM ROOM 103 ROOM 101 ROOM 102 ROOM 104 ROOM 105

09:00-11:00 SYM15 SYM16 SYM17 SYM18 SYM19 SYM20

Utilization Clinical application Traceability in the Updates on liquid APFCB Laboratory Haemoglobin A1c
management of of high sensitivity laboratory medicine biopsy monitoring of analysis; continual
laboratory test cardiac troponin – vital for clinical coagulation improvement
assays value
11:00-11:45 BREAK
11:45-12:30 PL 3
Adding clinical
utility to the
laboratory
reports
12:30-13:00 POSTER / LUNCH
13:00-14:00 LW 12 LW 14 Korean Student
Abbott Sysmex Session
12.00-14.00
Driving meaningful Hemostasis
cardiovascular analysis with
outcome with high Sysmex Laboratory
sensitive Troponin-I Solutions
in both patients 13.00-14.00
with chest pain and
apparently healthy
populations
13.00-14.00
14:30-15:30 IFCC SYM 5 EDUW33 SYM 30 SYM 32
Achieving BD Protein Essential
healthcare Electrophoresis leadership
excellence: Next Generation standardization skills: shaping
the UNIVANTS Blood Collection 14.30-16.30 future leaders
awards 2019 14.30-15.30 for success
16:00-17:00 15:00-17:00 in laboratory
management
14.30-16:30
17:30-18:30 SYM21 SYM22
The state of the art Clinical diabetes;
in myeloma testing is it time to change
16:30-18:30 practice?
16:30-18:30

THURSDAY 30 JUNE
AUDITORIUM ROOM 103 ROOM 101 ROOM 102 ROOM 104 ROOM 105

09:00-11:00 SYM23 SYM24 SYM25 SYM27 SYM28 APFCB -

Standardization Clinical WASPALM Advances in LIT symposium
and pathologists as a next generation
harmonization clinical consultant sequencing
of clinical
laboratory
results
11:00-11:45 BREAK
11:45-12:30 PL 4 APFCB
NGS analysis of
genetic diseases
12:30-13:00 CLOSING CEREMONY
 13

OPENING CEREMONY
26 JUNE
OPENING 17:30-19:30 - AUDITORIUM
LECTURE IFCC President Welcome Address
Khosrow Adeli
APFCB President Welcome Address
Endang Hoyaranda
Congress President Welcome Address
Won-Ki Min

IFCC DISTINGUISHED AWARDS PRESENTATION

Prof. Nader RIFAI (United States)
Dr Ghassan SHANNAN (Syria)
Dr Thomas ANNESLEY (United States)
Dr Andrea FERREIRA-GONZALEZ (United States)
Dr David B. SACKS (United States)
Dr Gary L. MYERS (United States)
Dr Fred S. APPLE (United States)
Dr Jean Baptiste WOILLARD (France)
Dr Sandra QUIJANO (Colombia)
Dr Livia S. EBERLIN (United States)

OPENING LECTURE
ALMIGHTY GOOGLE KNOWS EVERYTHING ABOUT YOU!
Hawoong Jeong (Korea)

Prof. Hawoong Jeong is currently professor of physics and director of BK21+

program at KAIST, Korea.
He got his Ph.D. in physics at Seoul National University, and his research
area includes big-data, complex systems, statistical/computational physics and
interdisciplinary science.He published about 100 research papers with more than
20,000 citations in diverse areas including physics, computer science, social
H. JEONG science and biology.
(Korea) He got several awards including KAIST best lecturer, KPS Yongbong prize, the
Scientist of the month award.
He has also been selected as Young Scientist at 2012 Summer Davos World
Econo Forum.

19:30 Welcome Cocktail Reception

14

DAY 1
MONDAY 27 JUNE
09:00-11:00

SYMPOSIUM 1 - AUDITORIUM
APPLICATIONS OF DATA SCIENCE TO THE IMPROVEMENT OF LABORATORY PRACTICE
Chair: T. Badrick (USA)

Artificial intelligence and pathology data

T. Durant (USA)

Real time patient QC - middleware requirements and model validation

T. Badrick (Australia)

Open source tools for quality monitoring and utilization management

D. Holmes (Canada)

Application of big data to routine laboratory tests in a large hospital network

H. H. Kim (Korea)

T. DURANT T. BADRICK D. HOLMES H.H. KIM

(USA) (Australia) (Canada) (Korea)

SYMPOSIUM 2 - ROOM 103

BEST LABORATORY PRACTICES FOR KIDNEY DISEASE
Chairs: T. Jeong (Korea)

Clinical utility of biomarkers for acute kidney Injury

J. M. El-Khoury (USA)

Diagnostic proteomic markers to detect kidney diseases

T. Ozben (Turkey)

The role of laboratory testing in detection and classification of chronic kidney disease
T. D. Jeong (Korea)

Estimating GFR – what’s next?

G. Jones (Australia)

J.M. EL-KHOURY T. OZBEN T.D. JEONG G. JONES

(USA) (Turkey) (Korea) (Australia)
 15
SYMPOSIUM 3 - ROOM 101
VALUE ADDED LABORATORY MEDICINE OF POINT-OF-CARE TESTING (POCT)
Chair: S. Cho (Korea)

Risk management and regulatory changes for POCT

J. H. Nichols (USA)

POCT for patients with infectious diseases in Africa

R. Erasmus (South Africa)

Issues in the practical implementation of POCT: overcoming challenges

H.D. Park (Korea)

J. H. NICHOLS R. ERASMUS H.D. PARK

(USA) (South Africa) (Korea)

SYMPOSIUM 4 - ROOM 102

TO KNOW EACH OTHER IN MASS SPECTROMETRY
Chair: H.D. Park (Korea)

Mass spectrometry versus immunoassay: one side does not fit all
K. Lee (Korea)

An ACTH mass spectrometry assay as an arbiter of clinally discordant immunoassay results

M. DeMarco (Canada)

Mass spectrometry and driving under the influence of marijuana

R. Fitzgerald (USA)

K. LEE M. DEMARCO R. FITZGERALD

(Korea) (Canada) (USA)
16

SYMPOSIUM 5 - ROOM 104

CURRENT STATUS OF ACCREDITATION ACTIVITIES IN LABORATORY MEDICINE: DO WE NEED IT TO BECOME
OBLIGATORY?
Chair: S. Kim (Korea)

Accreditation of medical laboratories – an ongoing work

T. Zima (Czech Republic)

How accreditation has IMPROVED laboratory testing

M. Herrmann (Austria)

External quality assurance-reducing between laboratory analytical variation

W. I. Lee (Korea)

H. HERRMANN W.I. LEE T. ZIMA

(Austria) (Korea) (Czech Republic)

IFCC SYMPOSIUM 1 - ROOM 105

A NEW ERA IN MEDICAL LABORATORY DIAGNOSTICS MANAGEMENT: APPLICATION OF ADVANCED MOBILE &
WEB TECHNOLOGY
Chair: T.Pillay (South Africa)

Role of technology in patient management and precision medicine

T. Pillay (South Africa)

Mobile technology and management of instruments

R. Greaves (Australia)

Using mobile technology to manage big data collections

K. Adeli (Canada)

New developments in web technology to enable medial diagnostics lab management

D. Topcu (Argentina)

T. PILLAY R. GREAVES K. ADELI D. TOPCU

(South Africa) (Australia) (Canada) (Argentina)

11:00-11:45 COFFEE BREAK

 17

27 JUNE
PLENARY 1 11:45-12:30

PLENARY 1 - AUDITORIUM
MAXIMIZING THE VALUE OF LABORATORY MEDICINE IN KOREA
Won-Ki Min (Korea)

Professor Won-Ki Min is the Congress President of IFCC Worldlab Seoul 2020.
Currently he is a Professor of Laboratory Medicine at the University of Ulsan
College of Medicine and works as a laboratory physician at Asan Medical Center,
a large training hospital located in Seoul, Korea.

After getting his M.D. from the College of Medicine, Seoul National University, he
received his PhD degree in Medical Science from Seoul National University and
Master of Science degree from Sogang University, both in Seoul, Korea.

His main area of research is laboratory informatics and quality assurance in the
W.K. MIN field of laboratory medicine.
(Korea)
Professor Min has been recognized with many awards and was a board member
of the Korean Medical Association as a director of information management.

Dr. Min has been actively serving in Korean academic societies: as chairperson
of the Korean Society for Laboratory Medicine, chairperson of the Laboratory
Medicine Foundation and chairperson and director of the Korean Institute of
Genetic Testing Evaluation. He also served as the chairperson of the organizing
committee for international meetings such as the 12th Asian-Pacific Congress
of Clinical Biochemistry in 2010 and the 8th International Conference of Clinical
Laboratory Automation in 2012.

Currently, he serves as the president of the Korean Association of External

Quality Assessment Service (KEQAS).
18

12:30-13:00 POSTER / LUNCH

13:00-14:00 LUNCH WORKSHOPS

14:30-18:30 EDUCATIONAL WORKSHOPS

15:00-17:00

IFCC SYMPOSIUM 2 - AUDITORIUM

USING BIG DATA FOR IMPROVING HEALTHCARE
Chair: M. Ferrari (Italy)

Aging and big data: a challenge for laboratory medicine

M. Ferrari (Italy)

The future of cancer care through biologic profiling and big data
D. Cacchiarelli (Italy)

M. FERRARI D. CACCHIARELLI
(Italy) (Italy)

16:30-18:30

SYMPOSIUM 6 - ROOM 104

STATE OF THE ART; PROFICIENCY TESTING
Chair: S. Chun (Korea)

UK NEQAS: building on 50 years of experience

F. Mackenzie (UK)

Introduction to the College of American Pathologists

D. Alter (USA)

Down under EQA

T. Badrick (Australia)

Korean Association of External Quality Assessment Service and Proficiency Testing

S. Chun (Korea)

F. MACKENZIE D. ALTER T. BADRICK S. CHUN

(UK) (USA) (Australia) (Korea)
 19
SYMPOSIUM 7 - ROOM 105
ISSUES ON METHOD EVALUATION
Chair: M. Han (Korea)

Fundamentals of method evaluation: principles behind the practice

M. D. Kellogg (USA)

Performance evaluation and clinical communication after analytical system change for D-dimer
W. Cui (P.R. China)

Real-world clinical laboratory practices of method evaluation for clinical chemistry test items
M. Han (Korea)

M.D. KELLOGG W. CUI M. HAN

(USA) (P.R. China) (Korea)

20

COMPANIES’ EDUCATIONAL WORKSHOPS

MONDAY 27 JUNE

LUNCH WORKSHOP 1 13.00 – 14.00 ROOM 103

ROCHE
Lunch will be offered by the company

Chair: Wesley Wong (Singapore)

THE GOLDEN AGE OF THE CLINICAL LAB AS WE TRANSITION FROM VOLUME TO VALUE -
CLINICAL LAB 2.0 MOVEMENT
Khosrow R. Shotorbani (USA)

LUNCH WORKSHOP 2 13.00 – 14.00 ROOM 101

BINDING SITE
Lunch will be offered by the company

WORKFLOW SOLUTIONS FOR THE MANAGEMENT OF MONOCLONAL GAMMOPATHIES AND

PRIMARY IMMUNODEFICIENCIES – FREELITE®, HEVYLITE® AND IGG SUBCLASSES
Woochang Lee (Korea)

LUNCH WORKSHOP 4 13.00 – 14.00 ROOM 104

SIEMENS HEALTHINEERS
Lunch will be offered by the company

Chair: Jeong-Ho Kim

UTILIZING HIGH-SENSITIVITY CARDIAC TROPONIN ASSAYS FOR IMPROVED EARLY DIAGNOSTICS:
LABORATORY MEDICINE AND CLINICAL PRACTICE GUIDELINES

Laboratory medicine’s role in appropriate clinical utilization of high-sensitivity cardiac troponin assays
Fred Apple (USA)
High-sensitivity cardiac troponin in managing acute chest pain patients – importance of securing proper
assay’s analytical performance
Yeo-Min Yun (Korea)

EDUCATIONAL WORKSHOP 2 14.30 – 15.30 ROOM 103

ROCHE

CARDIAC BIOMARKERS: THE KEY TO EARLY INTERVENTION

ESC 0/1-hr and 0/2-hr algorithms with hs-cTn in the ED- Clinical experience sharing
Cynthia Papendick (Australia)
NTproBNP in T2DM- Introduction to a new clinical indication
Bee Yong Mong (Singapore)

EDUCATIONAL WORKSHOP 3 16.00 – 17.00 ROOM 103

SEEGENE MEDICAL FOUNDATION

Chair: KyouSup Han (Korea)

RESPONSE OF SEEGENE MEDICAL FOUNDATION ON COVID-19 PANDEMIC
N. Sung (Korea)
 21

EDUCATIONAL WORKSHOP 5 14.30 – 15.30 ROOM 101

SNIBE DIAGNOSTIC

Chair: Aamir Ijaz (Pakistan)

THYROID ASSAYS: WHERE DO WE STAND?
Sergio Bernardini (Italy)

EDUCATIONAL WORKSHOP 8 14.30 – 15.30 ROOM 102

GC LABS

Chair: EunHee Lee (Korea)

DIAGNOSTICS AND TESTING LANDSCAPE BEYOND COVID-19: DYNAMICS OF AN EVOLVING
MARKET
Lain Barton (South Africa), Lelio Marmora (Switzerland), Sunghoon Kwon (Korea), Hyosoon Park (Korea),
EunHee Lee (Korea), Unyoung Go (Korea)

EDUCATIONAL WORKSHOP 9 16.00 – 17.00 ROOM 102

GC GENOME

Chair: Chang-Seok Ki (Korea)

AI-BASED LIQUID BIOPSY TEST
Eun-Hae Cho (Korea)
AI-BASED NON-INVASIVE PRENATAL TEST (NIPT)
Junnam Lee (Korea)
ASSOCIATION OF GUT MICROBIOME AND HYPERTENSION
Ju.Sun Song (Korea)

EDUCATIONAL WORKSHOP 11 14.30 – 15.30 ROOM 104

SIEMENS HEALTHINEERS

Chair: HwanSub Lim (Korea)

SERUM FREE LIGHT CHAINS ASSAYS: ANALYTICAL AND CLINICAL PERFORMANCE ON
DIFFERENT ANALYZERS
N Latex FLC assays for today’s labs
Christian Mirwaldt (Germany)
Clinical implication by differential analytical performances of serum free light chain quantitation analysis
using fully automated analyzers.
Jong-Baeck Lim (Korea)

EDUCATIONAL WORKSHOP 12 15.30 – 16.30 ROOM 104

ARKRAY

Chair: Junghan Song (Korea)

HBA1C IN THE MONITORING, DIAGNOSIS AND SCREENING OF DIABETES: VIEWS ON QUALITY
REQUIREMENTS IN RELATION TO ITS CLINICAL USE
Erna Lenters-Westra (The Netherlands)
ANALYTICAL PERFORMANCE EVALUATION OF THE ARKRAY ADAMS HA-8190V HBA1C ANALYZER
Joon Hee Lee (Korea)
22

COMPANIES’ EDUCATIONAL WORKSHOPS

MONDAY 27 JUNE

EDUCATIONAL WORKSHOP 13 14.30 – 15.30 ROOM 105

BECKMAN COULTER

INTELLIGENT AUTOMATION FOR ALL: ADVANCED INTELLIGENT AUTOMATION CAN HELP LABS
OF ALL SIZES IMPROVE WORKFLOW, SAMPLE TURNAROUND TIME (TAT) AND HEALTHCARE
DELIVERY
Alessandro di Marzio (Italy), Elassal Tamer Elassal (United Arab Emirates)

EDUCATIONAL WORKSHOP 14 15.30 – 16.30 ROOM 105

ORTHO CLINICAL DIAGNOSTICS

IN-VITRO DIAGNOSTICS IN ACUTE AND CRITICAL CARE – MAKE THE RIGHT DECISIONS FOR
YOUR MOST IMPORTANT PATIENTS AND DRIVE IMPROVED CLINICAL AND HEALTH ECONOMIC
OUTCOMES WITH DIAGNOSTICS.
C. Palaniappan (USA)
NOVEL HBA1C ENZYMATIC MICROSLIDE DRY CHEMISTRY ASSAY
M. Upadhyay (India)
24

DAY 2
TUESDAY 28 JUNE
09:00-11:00

SYMPOSIUM 8 - AUDITORIUM
APPLYING EVIDENCE-BASED GUIDELINES TO INCREASE CLINICAL EFFECTIVENESS IN LABORATORY MEDICINE
Chair: J. Lim (Korea)

To what degree is laboratory medicine evidence based?

A.R. Horvath (Australia)

What is the evidence base for setting (concrete) analytical performance specifications?
S. Sandberg (Norway)

The laboratory and hypertension - adding value to the clinical guidelines

S. Bhargava (India)

Can patient outcomes be evaluated by laboratory tests?

J. Lim (Korea)

A.R. HORVATH S. SANDBERG S. BHARGAVA J. LIM

(Australia) (Norway) (India) (Korea)

SYMPOSIUM 9 - ROOM 103

IMPLEMENTATION OF PHARMACOGENOMICS IN THE CLINIC
Chairs: S.Y. Lee (Korea), R. van Schaik (the Netherlands)

PGx information in clinical guidelines

R. van Schaik (the Netherlands)

TDM and PGx: complementary tools for precision medicine

S.Y. Lee (Korea)

Reporting tools and interpretive services to facilitate PGx test utilization

H. Hachad (USA)

R. VAN SCHAIK S.Y. LEE H. HACHAD

(the Netherlands) (Korea) (USA)
 25
SYMPOSIUM 10 - ROOM 101
ETHICAL ISSUES IN LABORATORY MEDICINE
Chair: S.J. Kim (Korea)

Ethical issues in emerging infections and the clinical laboratory

S. Campbell (USA)

Ethical issues in proficiency testing

J. W. Chung (Korea)

Ethical issues in clinical research

S. J. Kim (Korea)

S. CAMPBELL J.W. CHUNG S. J. KIM

(USA) (Korea) (Korea)

SYMPOSIUM 11 - ROOM 102

FUTURE APPLICATION OF AUTOMATION IN CLINICAL LABORATORY
Chair: Y.W. Lee (Korea)

Considerations of valuable technologies for total laboratory automation

Y. W. Lee (Korea)

The arrival of a new era of clinical laboratories with fully automated LCMS systems
D. Kawakami (Japan)

Differentiation of hematological disorders using the scattergrams of Sysmex automated hematology analyzer XN series
K. Han (Korea)

Y.W. LEE D. KAWAKAMI K. HAN

(Korea) (Japan) (Korea)
26

SYMPOSIUM 12 - ROOM 104

THE ROLE OF LABORATORY IN THE MANAGEMENT OF SEPSIS
Chair: M. Hur (Korea)

Clinical guidelines for interpreting PCT results

T. Van Schooneveld (USA)

Monitoring and improving clinical impact of PCT

G. Seymann (USA)

Application of heparin-binding protein as a biomarker of sepsis and infection

M. Guan (P.R. China)

Emerging biomarkers in sepsis

M. Hur (Korea)

T. VAN G. SEYMANN M. GUAN M. HUR

SCHOONEVELD (USA) (China) (Korea)
(USA)

IFCC SYMPOSIUM 3 - ROOM 105

THE FUTURE OF STANDARDIZATION IN LABORATORY MEDICINE: CHALLENGES AND OPPORTUNITIES
Chair: P. Gillery

Standardization and harmonization of biological measurements: successes, pitfalls and challenges

P. Gillery (France)

Importance of commutability for metrological traceability in standardization and harmonization
G. Miller (USA)

Challenges in test standardization: a manufacturer’s perspective

G. Wilkins (USA)

Proteoform analysis to fulfil unmet clinical and standardization needs
C. Cobbaert (the Netherlands)

P. GILLERY G. MILLER G:WILKINS C. COBBAERT

(France) (USA) (USA) (the Netherlands)

11:00-11:45 COFFEE BREAK

 27

28 JUNE
PLENARY 2 11:45-12:30

PLENARY 2 - AUDITORIUM
PHARMACOGENOMICS: FROM DISCOVERY TO CLINIC
Kathleen M. Giacomini (USA)

Dr. Giacomini is a Professor in the Department of Bioengineering and Therapeutic

Sciences at the University of California, San Francisco. She is currently Co-
Principal Investigator of the NIH Pharmacogenomics Research Network Hub,
and Co-Principal Investigator of the UCSF-Stanford Center of Excellence in
Regulatory Sciences and Innovation (CERSI), a major center funded by the FDA
with the goal of advancing scientific issues related to the safe and effective use of
K.M. GIACOMINI medical products. Dr. Giacomini is considered a leader in the field of membrane
(USA) transporters, and in particular, she is widely recognized for her work on transporter
genomics and pharmacogenomics. Dr. Giacomini has been recognized by many
awards and is an elected member of the National Academy of Medicine. She is
a recipient of an honorary doctoral degree from Uppsala University, and was
awarded the North American Scientific Achievement Award from the International
Society for the Study of Xenobiotics in 2017. Most recently in 2018, Dr. Giacomini
was awarded the Volwiler Research Achievement Award and was recognized by
her peers as one of the leading researchers in Pharmaceutical Sciences.
28

12:30-13:00 POSTER / LUNCH

13:00-14:00 LUNCH WORKSHOPS

14:30-18:30 EDUCATIONAL WORKSHOPS

15:00-17:00

IFCC SYMPOSIUM 4 - AUDITORIUM

EMERGING TECHNOLOGIES: NEW TRENDS AND CLINICAL APPLICATIONS
Chair: S. Bernardini (Italy)

Lipidomics translation
M. Hersberger (Switzerland)

Molecular diagnostics for guiding drug therapy: implementation of pharmacogenetics in clinical care
R. van Schaik (the Netherlands)

AI, machine learning and deep learning in laboratory medicine

S. Bernardini (Italy)

Genomics in oncology
M. De Tayrac (France)

M. HERSBERGER R. VAN SCHAIK S. BERNARDINI M. DE TAYRAC

(Switzerland) (The Netherlands) (Italy) (France)
 29
16:30-18:30

SYMPOSIUM 13 - ROOM 104

THE MICROBIOME: PRESENT AND FUTURE CHALLENGES IN LABORATORY MEDICINE
Chair: N. Ryoo (Korea)

Definition of a healthy microbiome and if disturbed – how to shape it back to normal

L. Engstrand (Sweden)

Microbiota bank utilization in clinical microbiology

D. Yong (Korea)

MALDI-TOF mass spectrometry for routine use in clinical microbiology

N. Ryoo (Korea)

L. ENGSTRAND D. YONG N. RYOO

(Sweden) (Korea) (Korea)

SYMPOSIUM 14 - ROOM 105

THERAPEUTIC DRUG MONITORING: TECHNICAL AND CLINICAL EXPERIENCE
Chairs: K. Lee (Korea), T. van Gelder (the Netherlands)

Analytical quality requirements in TDM

M. Shipkova (Germany)

TDM and pharmacogenetics: competitors or friends?

T. van Gelder (the Netherlands)

TDM consultation service and dosing software

M. Ji (Korea)

TDM for immunosuppressive drugs in auto-immune disease

Y. Avihingsanon (Thailand)

M. SHIPKOVA T. VAN GELDER M. JI Y. AVIHINGSANON

(Germany) (the Netherlands) (Korea) (Thailand)

30

COMPANIES’ EDUCATIONAL WORKSHOPS

TUESDAY 28 JUNE

LUNCH WORKSHOP 6 13.00 – 14.00 ROOM 103

THERMO FISHER SCIENTIFIC
Lunch will be offered by the company

Chair: Sang Hoon Song (Korea)

CASCADION™: UNLOCK THE POWER OF LC-MS/MS IN YOUR CLINICAL LAB
Whole automated LC-MS/MS implementation in the clinical laboratory: opportunities & experiences
Maria Shipkova (Germany) / Eberhard Wieland (Germany)
Reach new heights in your lab with the Thermo Scientific™ Cascadion™ SM Clinical Analyzer
Michel Schmidt (Finland)

LUNCH WORKSHOP 7 13.00 – 14.00 ROOM 101

ABBOTT
Lunch will be offered by the company

Chair: Mi Kyung Lee (Korea)

TOTAL LABORATORY SOLUTION HELPING LABS TO ACHIEVE OPERATIONAL EXCELLENCE
Exclusive Insights to the Automation Journey
Shweta Uppal (Abu Dhabi)
Driving clinicians and patient’s satisfaction through clinical lab excellence
Sanja Stankovic (Serbia)

LUNCH WORKSHOP 8 13.00 – 14.00 ROOM 102

GC MS
Lunch will be offered by the company

Chiar: Yoon Jeong, Cho (Korea)

THE NATURE OF SMART DNA POLYMERASE MAKES THE DIFFERENCE OF LIQUID BIOPSY
Byungchul Lee (Korea)
NEW PETIA FOR PROCALCITONIN – ROUTINE EXPERIENCE AND LESSONS LEARNED FROM EQA
EVALUATION
Matthias Grimmle (Germany)

LUNCH WORKSHOP 9 13.00 – 14.00 ROOM 104

SYSMEX
Lunch will be offered by the company

Chair: Mina Hur (Korea)

HEMATOLOGY AND SEPSIS WITH SYSMEX LABORATORY SOLUTIONS
Clinical Significance of cell population data on Sysmex XN-3100 in septic patients
Mitsuho Watanabe (Japan)
 31

EDUCATIONAL WORKSHOP 16 14.30 – 15.30 ROOM 103

ROCHE

Chair: Wesley Wong (Singapore)

IMPROVEMENT INSIGHTS FROM CLINICAL LAB BENCHMARKING SURVEY
Tony Badrick (Australia)

EDUCATIONAL WORKSHOP 17 16.00 – 17.00 ROOM 103

SNIBE DIAGNOSTIC

Chair: Saeed Mohammed Alamoudi (Saudi Arabia)

TOTAL & FREE-TESTOSTERONE ASSAYS IN SUPPORT OF DIAGNOSIS OF HYPOGONADISM AND
FERTILITY
Waleed Altamimi (Saudi Arabia)
THE MOLECISION SARS-CoV-2 RT-PCR AND THE RAPISAFE ANTIGEN TEST IN FIGHTING THE
PANDEMIC
Mirna Germanos (Lebanon)

EDUCATIONAL WORKSHOP 19 14.30 – 15.30 ROOM 101

BECKMAN COULTER

MONOCYTE DISTRIBUTION WIDTH, NEW CELLULAR BIOMARKER

S. Hong (Korea), Elena Sukhacheva (Usa)

EDUCATIONAL WORKSHOP 21 17.30 – 18.30 ROOM 101

HANDOK

Chair: Soo-Youn Lee

TARGETED OMICS FOR CLINICAL AND TRANSLATIONAL RESEARCH
M. Ritchie (UK)

EDUCATIONAL WORKSHOP 22 14.30 – 15.30 ROOM 102

SIEMENS HEALTHINEERS

Chair: HyungHoi Kim

THE VALUE OF ELF TEST IN THE SCREENING AND MANAGEMENT OF NON-ALCOHOLIC FATTY
LIVER DISEASE
Elizabeth Powell (Australia)

EDUCATIONAL WORKSHOP 25 14.30 – 15.30 ROOM 104

SEBIA

Chair: Junghan Song (Korea)

NEW OPPORTUNITIES TO MEASURE HBA1C BY CAPILLARY ELECTROPHORESIS
HBA1C for the diagnosis and monitoring of Diabetes Mellitus: understanding the clinical value and
potential limitations
D.B. Sacks (South Africa)
Features to consider when choosing a new method for HBA1C
A.Mosca (Italy)
32

COMPANIES’ EDUCATIONAL WORKSHOPS

TUESDAY 28 JUNE

EDUCATIONAL WORKSHOP 27 14.30 – 15.30 ROOM 105

SCL

Chair: Sang-Hoon Song, M.D

CLINICAL LABORATORY APPLICATION OF MASS SPECTROMETRY
Routine use and application of maldi-tof ms in clinical microbiology laboratories
Jae-Seok Kim (Korea)
Applications and challenges in using lc-ms/ms assays for quantitative hormone analysis
Hyun-Kyung Park (Korea)

EDUCATIONAL WORKSHOP 28 15.30 – 16.30 ROOM 105

A&T Corporation

Chair: Sang-Hoon Song, M.D

INTRODUCTION OF GREEN CROSS LABORATORIES & TOTAL LABORATORY AUTOMATION
SYSTEM
Sun Hyun Ahn (Korea)
WHAT ARE PRE-ANALYTICAL ERRORS
COSTING YOUR LAB?

Meet the DxA 5000 Fit, the workflow solution that identifies up to 70%
of the most common pre-analytical errors within the first 3 seconds
of touching each tube.

See it at Booth #68 to believe it!

Learn more at BeckmanCoulter.com/DxA5000Fit

© 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the
Beckman Coulter product and service marks mentioned herein are trademarks or registered
trademarks of Beckman Coulter, Inc. in the United States and other countries.

For Beckman Coulter’s worldwide office locations and phone numbers, please visit
www.beckmancoulter.com/contact

HGM2022-085 | 2022-10172
34

DAY 3
WEDNESDAY 29 JUNE
09:00-11:00

SYMPOSIUM 15 - AUDITORIUM
UTILIZATION MANAGEMENT OF LABORATORY TEST
Chair: Y.M. Yun (Korea)

Help me help you: Guidelines to elevate laboratory stewardship programs

J. Dickerson (USA)

Applying analytics to drive laboratory stewardship and improve care

P.C. Mathias (USA)

Experience of utilization management in the real-world / When should a test be repeated

S. H. Song (Korea)

J. DICKERSON P.C. MATHIAS S. H. SONG

(USA) (USA) (Korea)

SYMPOSIUM 16 - ROOM 103

CLINICAL APPLICATION OF HIGH SENSITIVITY CARDIAC TROPONIN ASSAYS
Chair: S.G. Lee (Korea)

Biology and quality specification of troponin assays

S. G. Lee (Korea)

Utilization of hs troponins in the emergency room setting

M. Than Nyunt (New Zealand)

Novel uses of hs troponins (monitoring cardiac toxicity of chemotherapy, etc.)

A. K. Saenger (USA)

Standardization of hs-troponin I assays, where are we?

F. S. Apple (USA)

S. G. LEE M. THAN NYUNT A. K. SAEGER F. S. APPLE

(Korea) (New Zealand) (USA) (USA)
 35
SYMPOSIUM 17 - ROOM 101
TRACEABILITY IN THE LABORATORY MEDICINE – VITAL FOR CLINICAL VALUE
Chair: I. Young (UK)

Metrological traceability – what is it?

R. Wielgosz (France)

Traceability for laboratory medicine – the role of the JCTLM

I. Young (UK)

Traceability in action
A. Kessler (Germany)

Traceability in the routine laboratory

G. Jones (Australia)

Subsequent Decisions
S. R. Park (Korea)

R. WIELGOSZ I. YOUNG A. KESSLER G. JONES S. R. PARK

(France) (UK) (Germany) (Australia) (Korea)

SYMPOSIUM 18 - ROOM 102

UPDATES ON LIQUID BIOPSY
Chair: W. Lee (Korea)

CTC analysis: an overview of CTC isolation, detection and molecular characterization technologies
E. Lianidou (Greece)

Past, present and the future of circulating DNA in prenatal diagnosis

A. Chan (Hong Kong, P.R. China)

Current and future perspectives of liquid biopsies in genomics-driven oncology

E. Heitzer (Austria)

Liquid biopsy as a part of clinical laboratory practices: the status of external quality assessment (EQA) for liquid biopsy
W. Lee (Korea)

E. LIANIDOU A. CHAN E. HEITZER W. LEE

(Greece) (Hong Kong, (Austria) (Korea)
P.R. China)
36

APFCB SYMPOSIUM 19 - ROOM 104

LABORATORY MONITORING OF COAGULATION
Chair: J.Y. Han (Korea)

Misconceptions in routine coagulation testing

S. Jang (Korea)

Common pitfalls in testing and interpretation of D-dimers

E. Favaloro (Australia)

Laboratory monitoring of coagulation disorders by clot waveform analysis

M. Shima (Japan)

S. JANG E. FAVALORO M. SHIMA

(Korea) (Australia) (Japan)

SYMPOSIUM 20 - ROOM 105

HAEMOGLOBIN A1C ANALYSIS; CONTINUAL IMPROVEMENT
Chair: G. John (UK)

The HbA1c story: the successful development of full metrological traceability in laboratory medicine
G. John (UK)

How good is HbA1c analysis? Latest country and manufacturer results from the IFCC international quality assessment trial,
using sigmametrics as a monitor of performance
E. Lenters (the Netherlands)

POCT for HbA1c: requirements for reliable clinical use

J. Song (Korea)

HbA1c analysis, what really affects the result and interpretation?

E. English (UK)

G. JOHN E. LENTERS J. SONG E. ENGLISH

(UK) (the Netherlands) (Korea) (UK)

11:00-11:45 COFFEE BREAK

 37

29 JUNE
PLENARY 3 11:45-12:30

PLENARY 3 - AUDITORIUM
ADDING CLINICAL UTILITY TO THE LABORATORY
REPORTS
Wytze P Oosterhuis (the Netherlands)

Wytze Oosterhuis was born in Amsterdam, The Netherlands. He studied both

physical chemistry and medicine, and ended his specialization in laboratory
medicine in 1991. In 1994 he completed his thesis on applications of multivariate
analysis in clinical chemistry and was registered as medical epidemiologist. He
has been active for the IFCC, first in the Committee on Systematic Reviewing,
chaired by Prof. Sverre Sandberg. Later this committee was renamed Committee
W.P. OOSTERHUIS on Evidence Based Laboratory Medicine (EBLM). This committee has prepared
(the Netherlands) many publications and presented several courses. Within the European Federation
of Clinical Chemistry and Laboratory Medicine (EFLM) he is member of the
Working Group on Guidelines, a joint activity of both EFLM and European Union
of Medical Specialists (UEMS). He is also chair of the EFLM Working Group on
Patient Focused Laboratory Medicine. From 2014 until 2017 he chaired the EFLM
Task and Finish group on Total Error. His scientific work centers on consultation,
in general adding value to laboratory results. He works as a laboratory physician
in Zuyderland Medical Center, a large training hospital located in Sittard and
Heerlen, The Netherlands.
38

12:30-13:00 POSTER / LUNCH

13:00-14:00 LUNCH WORKSHOPS

14:30-18:30 EDUCATIONAL WORKSHOPS

SYMPOSIUM 30 - ROOM 104

PROTEIN ELECTROPHORESIS STANDARDIZATION
Chair: R.A. Booth (Canada)

Canadian Society of Clinical Chemists recommendations for protein electrophoresis reporting

R. A. Booth (Canada)

CAP recommendations: initial detection and measurement of a monoclonal protein

D. Keren (USA)

Update on recommendations for standardised reporting of protein electrophoresis in Australia and New Zealand
P. Mollee (Australia)

Experience of transition from narrative to synoptic reporting for protein electrophoresis and immunofixation
H.K. Kim (Korea)

R.A. BOOTH D. KEREN P. MOLLEE H.K. KIM

(Canada) (USA) (Austrlia) (Korea)

SYMPOSIUM 32 - ROOM 105

ESSENTIAL LEADERSHIP SKILLS: SHAPING FUTURE LEADERS FOR SUCCESS IN LABORATORY MANAGEMENT
Chair: P. Sharma (India)

Leadership attributes and styles: Impact on relationships in the workplace

E. W. Randell (Canada)

The Leader versus the manager and building leadership through emotional intelligence
P. Sharma (India)

Developing an effective leadership style in laboratory team management

S. Yenice (Turkey)

Managing relationships and leading changes within the heterogeneous workplace

A. A. Khine Wamono (South Africa)

E.W. RANDELL P. SHARMA S. YENICE A.A. KHINE WAMONO

(Canada) (India) (Turkey) (South Africa)
 39
15:00-17:00

IFCC SYMPOSIUM 5 - AUDITORIUM

ACHIEVING HEALTHCARE EXCELLENCE: THE UNIVANTS AWARDS 2019
Chair: M. Ferrari (Italy)

The importance of our profession promoting the value of laboratory medicine

D. Kinniburgh (Canada)

The developing role of angiogenic markers in the laboratory assessment of pre-eclampsia

T. James (UK)

Improved diagnostic pathway and treatment for hospitalized patients with acute kidney injury
S. Elitok (Germany)

D. KINNIBURGH T. JAMES S. ELITOK

(Canada) (UK) (Germany)

16:30-18:30

SYMPOSIUM 21 - ROOM 104

THE STATE OF THE ART IN MYELOMA TESTING
Chair: H. Chae (Korea)

Should mass spectrometry replace electrophoresis and free light chain analysis?
D. Murray (USA)

Biomarkers of myeloma nephropathy: from MGUS to symptomatic myeloma

I. Papasotiriou (Greece)

Protein electrophoresis interpretation and reporting

H. Chae (Korea)

D. MURRAY I. PAPASOTIRIOU H. CHAE

(USA) (Greece) (Korea)
40

SYMPOSIUM 22 - ROOM 105

CLINICAL DIABETES; IS IT TIME TO CHANGE PRACTICE?
Chairs: J. Song (Korea), G. John (UK)

Type 2 diabetes; is Asia different from the West?

L. Ji (P.R. China)

Complimentary markers of glycaemic control: uses and limitations in clinical practice

E. Kilpatrick (Qatar)

Interpretation of HbA1c results, new targets and new uses. Is it time for change?
S. Atkin (Qatar)

Is bariatric surgery a cure for type 2 diabetes?

C. Le Roux (Ireland)

L. JI E. KILPATRICK S. ATKIN C. LE ROUX

(P.R. China) (Qatar) (Qatar) (Ireland)

 41

COMPANIES’ EDUCATIONAL WORKSHOPS

WEDNESDAY 29 JUNE

LUNCH WORKSHOP 12 13.00 – 14.00 ROOM 101

ABBOTT
Lunch will be offered by the company

Chair: John Thundyil

DRIVING MEANINGFUL CARDIOVASCULAR OUTCOME WITH HIGH SENSITIVE TROPONIN-I IN
BOTH PATIENTS WITH CHEST PAIN AND APPARENTLY HEALTHY POPULATIONS
Making meaningful impact to the care of chest pain patients with high sensitive Troponin-I and data
Martin Than (New Zealand)
Role of high sensitivity Troponin-I in advancing risk stratification in the apparently healthy population
Abraham Oomman (India)

LUNCH WORKSHOP 14 13.00 – 14.00 ROOM 104

SYSMEX
Lunch will be offered by the company

Chair: Jin Young Han (Korea)

HEMOSTASIS ANALYSIS WITH SYSMEX LABORATORY SOLUTIONS
Von Willebrand Syndrome, Update
Hisanori Horiuchi (Japan)

EDUCATIONAL WORKSHOP 33 14.30 – 15.30 ROOM 101

BD

NEXT GENERATION BLOOD COLLECTION

Felicitas Lacbawan (USA)
 We make
diagnostics
that

matter

At SEKISUI Diagnostics, what matters to you matters to us. Our whole purpose is to partner
with you to provide intelligent solutions that enable you to make a timely difference.
Because we both understand that there is a patient behind every answer—and that’s
what matters most.

For more information about our assays and systems, please visit sekisuidiagnostics.com
or email us at [email protected]

Clinical Chemistry • Point-of-Care • Enzymes • Pre-Analytic Systems

© 2022 SEKISUI Diagnostics, LLC. All rights reserved. Because every result matters is a trademark of SEKISUI Diagnostics, LLC.
 43

DAY 4
THURSDAY 30 JUNE
09:00-11:00

SYMPOSIUM 23 - AUDITORIUM
STANDARDIZATION AND HARMONIZATION OF CLINICAL LABORATORY RESULTS
Chairs: Y.M. Yun (Korea), H. Vesper (USA)

CDC clinical standardization programs for clinical laboratory results

H. Vesper (USA)

The International Consortium for Harmonization of Clinical Laboratory Results (ICHCLR) – a pathway to harmonization
G. Myers (USA)

Commutability issues in standardization and harmonization of clinical laboratory results

G. Miller (USA)

Programs for standardization and harmonization of clinical laboratory results in Korea

Y. M. Yun (Korea)

H. VESPER G. MYERS G. MILLER Y. M. YUN

(USA) (USA) (USA) (Korea)

SYMPOSIUM 24 - ROOM 103

CLINICAL PATHOLOGISTS AS A CLINICAL CONSULTANT
Chair: S. Chun (Korea)

Clinical consultant in the field of clinical microbiology

J. Lee (Korea)

Clinical consultant in the field of genetics

D. Payne (USA)

Clinical consultant in the field of hematology

M. G. Shin (Korea)

Clinical consultant in the field of clinical chemistry

S. Stankovic (Serbia)

J. LEE D. PAYNE M. G. SHIN S. STANKOVIC

(Korea) (USA) (Korea) (Serbia)
44

SYMPOSIUM 25 - ROOM 101

WASPALM Symposium
Chair: R. Verna (Italy)

The importance of Laboratory Medicine in modern health economics and health promotion
L. Noguera Martins (Portugal)

Autoimmune Hypertriglyceridemia
M. Murakami (Japan)

Intelligent verification criteria for routine urinalysis procedure

W. Cui (P.R. China)

From alchemy to personalized medicine: the road of laboratory medicine

R. Verna (Italy)

L. NOGUERA MARTINS M. MURAKAMI W. CUI R. VERNA

(Portugal) (Japan) (P.R. China) (Italy)

SYMPOSIUM 27 - ROOM 104

ADVANCES IN NEXT GENERATION SEQUENCING
Chair: S.T. Lee (Korea)

Expanding application of next generation sequencing in clinical laboratory

J. Smetana (Czech Republic)

Recent application and validation of bioinformatics pipelines in NGS

S. T. Lee (Korea)

Guidelines, quality control and standardization of NGS testing

C. Endrullat (Germany)

NGS-guided precision medicine: point of view from clinicians

V. Shotelersuk (Thailand)

J. SMETANA S.T. LEE C. ENDRULLAT V. SHOTELERSUK

(Czech Republic) (Korea) (Germany) (Thailand)
 45

APFCB SYMPOSIUM 28 - ROOM 105

LIT Symposium
Chair: J. H. Lee (Korea)
The role of seamless informatics from LIS to Electronic Medical Records (EMR) to National Electronic Health Records
(NEHR)
T. P. Loh (Singapore)

Informatics Standards and Harmonisation – for critical results, automatic commenting, middleware, POC networking,
telehealth resulting
R. Flatman (Australia)
Laboratory Middleware Functionlaity and Automation Process Control
R. Pu (P.R. China)
LIS requirements for laboratory management
J. H. Lee (Korea)

T.P. LOH R. FLATMAN R. PU J.H. LEE

(Singapore) (Australia) (P.R. China) (Korea)
46

30 JUNE
PLENARY 4 11:45-12:30

APFCB PLENARY 4
NGS ANALYSIS OF GENETIC DISEASES
Naomichi Matsumoto (Japan)

Professor and Chair, Department of Human Genetics, Yokohama City University

Graduate School of Medicine
• Educational Background:
Kyushu University School of Medicine, M.D., 1986
Graduate School of Medical Science, Nagasaki University School of Medicine,
Ph.D., 1997
N. MATSUMOTO • Professional Experiences:
(Japan) 1986-1993 Obstetrician & Gynecologist at Kyshu University related hospitals
1993-1997 Graduate School of Nagasaki University, Department of Human
Genetics
1997-1998 Post Doctoral Fellow at Department of Human Genetics, The University
of Chicago
1998-2000.1 Research associate at Department of Human Genetics, The
University of Chicago
2000-2003 Associate professor at Department of Human Genetics, Nagasaki
University School of Medicine
2003-present Professor and Chair at Department of Human Genetics,
Yokohama City University Graduate School of Medicine
• Honors and awards
2003 Japan Society of Human Genetics Award for Young Scientist
2011 Japan Society of Human Genetics Award
2019 A Prize for Science and Technology, Research Category, The Commendation
for Science and Technology by the Minister of Education, Culture, Sports, Science
and Technology
• Professional Organizations
Member of Japan Society of Human Genetics (Councilor 2003-) (Director 2011-)
 47

CLOSING
CEREMONY THURSDAY 30 JUNE
12:30-13:00 Congress Report
Junghan Song (Korea)

IFCC Remarks
Khosrow Adeli (Canada)

Announcement IFCC WorldLab Dubai 2024

Khosrow Adeli (Canada)
Anwar Borai (Saudi Arabia)
Adberrazek Hedhili (AFCB)

APFCB Remarks
Endang Hoyaranda (Indonesia)

Announcement AACB Congress Perth 2022

Endang Hoyaranda (Indonesia)
Helen Martin (Australia)
48

CLOSED MEETINGS

SATURDAY, 25 JUNE 2022

08:30-18.00 IFCC Young Scientists Forum Room 205

09.00-17.00 IFCC C-NPU Meeting Room 210

SUNDAY, 26 JUNE 2022

09.00-16.30 IFCC CPD-EC Meeting Room 204

09:00-13.00 IFCC Young Scientists Forum Room 205
09.00-17.00 IFCC C-NPU Meeting Room 210
09.00-13.00 APFCB Council Meeting Room auditorium R3

MONDAY, 27 JUNE 2022

10.00-16.00 IFCC C-MD Meeting Room 207

11.30-13.30 IFCC Corporate Members Meeting Room 210
12.00-15.00 IFCC C-POCT Room 208
13.00-17.00 IFCC TF-GLQ Room 204
13.00-15.00 APFCB EB - Incoming and Outgoing Room 103A

TUESDAY, 28 JUNE 2022

09.00-13.00 IFCC C-CLM Meeting Room 211

09.00-17.00 IFCC AFCC Board Meeting Room 209B
10.00-17.30 IFCC C-CMBC Meeting Room 207
13.00-17.00 IFCC TF-YS Meeting Room 205
13.00-17.00 IFCC C-STFT Meeting Room 210
14.00-18.00 IFCC C-CC Meeting Room 211
12.00-14.00 APFCB - IFCC EB Meeting Room auditorium R3

WEDNESDAY, 29 JUNE 2022

09.00-16.00 IFCC ETD-EC Meeting Room 204

THURSDAY, 30 JUNE 2022

09.00-17.00 IFCC EB Meeting Room 207

FRIDAY, 1 JULY 2022

09.00-17.00 IFCC EB Meeting Room 207

50

SPEAKERS & CHAIRS

Adeli Khosrow, IFCC President, Pediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada
Alter David, Dept. of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
Apple Fred, Hennepin Healthcare, University of Minnesota School of Medicine, Minneapolis, MN, USA
Atkin Stephen, Royal College of Surgeons in Ireland in Bahrain
Avihingsanon Yingyos, Chulalongkorn University, Faculty of Medicine and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Thailand
Badrick Tony, Royal College of Pathologists of Australasia Quality Assurance Programs
Bernardini Sergio, Clinical Biochemistry and Clinical Molecular Biology, Tor Vergata University, Roma, Italy
Bhargava Seema, Department of Biochemistry Sir Ganga Ram Hospital, New Delhi, India
Booth Ronald, University of Ottawa, The Ottawa Hospital & Eastern Ontario Regional Laboratory Association, Canada
Cacchiarelli Davide, Telethon Institute of Genetics and Medicine, Italy
Campbell Sheldon, Yale School of Medicine, Dept. of Laboratory Medicine, New Haven, Connecticut, USA
Chae Hyojin, Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Chan Allen, Chemical Pathology, The Chinese University of Hong Kong
Cho Sun Young, Kyung Hee University Hospital, Seoul, Republic of Korea
Cho Sung-Eun, GC Labs, Gyeonggi-do, Republic of Korea
Chun Sail, Asan Medical Center, University of Ulsan, Republic of Korea
Chung Jae-Woo, Dongguk University Ilsan Hospital, Goyang, Republic of Korea
Cobbaert Christa, Afdeling Klinische Chemie en Laboratoriumgeneeskunde | LUMC, Leiden, The Netherlands
Cui Wei, Chinese Academy of Medical Sciences, Peking Union Medical College, P.R. China
DeMarco Mari, University of British Columbia, Vancouver, Canada
De Tayrac Marie, Rennes University Hospital, France
Dickerson Jane, UW Medicine, Seattle Children’s Hospital, Seattle, Washington, USA
Durant Thomas, Chemical Pathology Laboratory, Yale-New Haven Hospital, Connecticut, USA
El-Khoury Joe M., Clinical Chemistry and Laboratory Medicine, Yale University and Yale-New Haven Hospital, Connecticut, USA
Elitok Saban, Klinikum Ernst von Bergmann, Potsdam, Germany
Endrullat Christoph, MSD Sharp & Dohme GmbH, Koenigs Wusterhausen, Germany
English Emma, University of East Anglia, School of Health Sciences, Norwich, UK
Engstrand Lars, Centre for Translational Microbiome Research, Karolinska Institutet, Stockholm, Sweden
Erasmus Rajiv, Chemical Pathology, Stellenbosch University, Bellville, Cape Town, South Africa
Favaloro Emmanuel, Dept. of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Australia
Ferrari Maurizio, CMO, Synlab, Italy - IFCC Past President
Fitzgerald Robert, Dept. of Pathology, Center for Medicinal Cannabis Research, UC San Diego, California, USA
Flatman Robert, Biochemistry Dept. Sullivan Nicolaides Pathology, Brisbane, Australia
Giacomini Kathleen M., University of California, San Francisco, USA
Gillery Philippe, IFCC Scientific Division Chair, University Hospital and Faculty of Medicine, UMR CNRS / URCA, Reims, France
Greaves Ronda, Deputy Head Biochemical Genetics, Victorian Clinical Genetics Services, Victoria, Australia
Guan Ming, Fudan University Huashan Hospital, Shanghai, P.R. China
Hachad Houda, Vice President of Clinical Operations, AccessDx Laboratory, Houston, Texas, USA
Han Minje, Kangdong Sacred Heart Hospital, Seoul, Korea
Han Jin-Yeong, Department of Laboratory Medicine, Dong-A University College of Medicine, Busan, Korea
Han Kyungja, The Catholic University of Korea, Seoul, Korea
Heitzer Ellen, Diagnostic and Research Institute of Human Genetics, Medical University of Graz, Austria
Hermann Markus, Klinisches Institut für Medizinische und Chemische Laboratorsiagnostik, Medizinische Universität of Graz, Austria
Hersberger Martin, University-Children’s Hospital Zurich, Div. of Clinical Chemistry and Biochemistry, Switzerland
Holmes Daniel, University of British Columbia, Dept. of Pathology and Laboratory Medicine, Vancouver, Canada
Horvath Andrea Rita, Department of Chemical Pathology, The Prince of Wales Hospital, Randwick, Australia
Hur Mina, Konkuk University Medical Center, Seoul, Korea
James Timothy, Clinical Biochemistry, Oxford University Hospitals Nhs Foundation Trust, UK
Jang Seongsoo, Univ. of Ulsan School of Medicine, Asan Medical Center, Seoul, Korea
Jeong Hawoong, KAIST (Korea Advanced Institute of Science and Technology), Daejeon, Korea
Jeong Tae-Dong, Ewha Womans University, Seoul, Korea
Ji Misuk, Veterans Health Service Medical Center, Seoul, Korea
Ji Linong, Peking University People’s Hospital, Peking University Diabetes Center, P.R. China
John Garry, Norfolk & Norwich University Hospital, Norwich, UK
Jones Graham, St Vincent’s Hospital and University of NSW, Sydney, Australia
Kawakami Daisuke, Shimadzu Europa GmbH, Duisburg, Germany
Kellogg Mark D., Boston Children’s Hospital and Harvard Medical School, Massachusetts, USA
Keren David, Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA
Kessler Anya, Referenzinstitut für Bioanalytik, Bonn, Germany
Khine Wamono Aye Aye, Chemical Pathologist, Stellenbosch University, National Health Laboratory Service, South Africa
Kilpatrick Eric, Consultant in Chemical Pathology, Manchester Royal Infirmary, Manchester, UK
Kim Hyun-Ki, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea
Kim Hyung Hoi, Professor, Pusan National University Hospital, Busan, Korea
Kim Sollip, Inje University Ilsan Paik Hospital, Goyang, Korea
Kim Sun Joo, Dept Laboratory Medicine, Gyeongsang National University College of Medicine, Jinju, Korea
 51

Kinniburgh David, Director, Alberta Centre for Toxicology, University of Calgary, Canada
Le Roux Carel, St Vincent’s University Hospital, Dublin, Ireland
Lee Jaehyeon, Dept. of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, Korea
Lee Jehoon, President KSCC, Eunpyeong St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
Lee Kyunghoon, Seoul National University Bundang Hospitality, Seongnam, Korea
Lee Sang-Guk, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Lee Seung-Tae, Yonsei University College of Medicine, Seoul, Korea
Lee Soo-Youn, Samsung Medical Center, Seoul, Korea
Lee Woo In, Kyung Hee University Hospital at Gangdong, Seoul, Korea
Lee Woochang, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Lee Yong-Wha, Soonchunhyang Univ. Bucheon Hospital, Bucheon, Korea Lianidou Evi
Lenters Erna - Westra, European Reference Laboratory for Glycohemoglobin, Isala, Zwolle, Netherlands
Lianidou Evi, Analytical Chemistry Clinical Chemistry, Analysis of Circulating Tumor Cells (ACTC) Lab, Dept of Chemistry, University of Athens, Greece
Lim Jinsook, Chungnam National University Hospital, Daejeon, Korea
Loh Tze Ping, Clinical Chemistry Div., Dept. of Laboratory Medicine, National University Hospital, Singapore
Mackenzie Finlay, Birmingham Quality, UK NEQAS
Mathias Patrick C., Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, USA
Matsumoto Naomichi, Dept. of Human Genetics, Yokohama City University Graduate School of Medicine, Japan
Miller Gregory, Pathology Dept., Virginia Commonwealth University, Richmond, Virginia, USA
Min Won-Ki, Congress President, Asan Medical Center, Seoul, Korea
Mollee Peter, Pathology Queensland, Princess Alexandra Hospital, Brisbane, Australia
Murakami Masami, Dept. of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan
Murray David, Mayo Clinic, Rochester, Minnesota, USA
Myers Gary, Myers Consulting, Smyrna, Georgia, USA
Nichols James, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Nogueira Martins Luis, CML Germano de Sousa; Portuguese Society of Clinical Pathology (SPPC), Lisbon, Portugal
Oosterhuis Wytze, Reinier Haga Medical Diagnostics Centre, Delft, Netherlands
Ozben Tomris, EFLM President, Akdeniz University Medical Faculty Department of Clinical Biochemistry, Antalya, Turkey
Papasotiriou Ioannis, Department of Clinical Biochemistry, “Aghia Sophia” Children’s Hospital, Athens, Greece
Park Hyung-Doo, Samsung Medical Center, Seoul, Korea
Park Sang-Ryoul, Korea Research Institute of Standards and Science, Daejeon, Korea
Payne Deborah, Consultant at CPDP Consulting, Denver, Colorado, USA
Pillay Tahir, Dept. of Chemical Pathology University of Pretoria, Pretoria, South Africa
Pu Ryan, President of TCSoft in Shanghai and member of Laboratory Medicine Sub-Association affiliated to China Association of Medical Equipment
Randell Edward W., Memorial University, Newfoundland and Labrador, Canada
Ryoo Namhee, Keimyung University School of Medicine Department of Laboratory Medicine, Daegu, Korea
Saenger Amy, Hennepin Country Medical Center, University of Minnesota, Minneapolis, Minnesota, USA
Sandberg Sverre, The Norwegian Organisation for Quality Improvement of Laboratory Examinations, Bergen, Norway
Seymann Gregory, Div. of Hospital Medicine, Dept. of Medicin, University of California San Diego School of Medicine, USA
Sharma Praveen, Professor of Biochemistry, All India Instiutte of Medical Sciences, Jodhpur, India
Shima Midori, Thrombosis and Hemostasis Research Center, Nara Medical University, Nara, Japan
Shin Myung-Geun, Chonnam National University Hwasun Hospital, Hwasun-gun, Jeollanam-do, Korea
Shipkova Maria, SYNLAB Holding Germany, Stuttgart, Germany
Shotelersuk Vorasuk, Chulalongkorn University, Bangkok, Thailand
Smetana Jan, Dept. of Genetics and Molecular Biology, Institute of Experimental Biology, Brno, Czech Republic
Song Sang Hoon, Seoul National University Hospital, Seoul, Korea
Song Junghan, Seoul National Universtiy Bundang Hospital, Seongnam-si, Korea
Stankovic Sanja, University Clinical Center of Serbia, Faculty of Medical Sciences University of Kragujevac, Belgrade, Serbia
Than Nyunt Martin, Director of Emergency Medicine Research, Christchurch, New Zealand
Topcu Deniz, Baskent University Faculty of Medicine, Medical Biochemistry, Ankara, Turkey
van Gelder Teunis, Leiden University Medical Center, Leiden, Netherlands
van Schaik Ron H.N., Dept Clinical Chemistry, Erasmus MC, Rotterdam, Netherlands
Van Schooneveld Trevor, University of Nebraska Medical Center, Omaha, USA
Verna Roberto, President of WASPaLM, Roma, Italy
Vesper Hubert, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Wielgosz Robert, BIPM, JCTLM, Sèvres, France
Wilkins Geoff, Siemens Healthineers, USA
Yenice Sedef, Group Florence Nightingale Hospitals, Istanbul, Turkey
Yong Dongeun, Yonsei University Health System, Seoul, Korea
Young Ian, Queen’s University, Belfast, UK
Yun Yeo-Min, Konkuk University School of Medicine, Seoul, Korea
Zima Tomas, 1st Faculty of Medicine Charles University, General University Hospital, Prague, Czech Republic
52

SATELLITE MEETING

1 KSCC SATELLITE MEETING

Title: COVID-19 Diagnosis and Quarantine
Date: June 25 (Sat), 2022
Time: 14:00~20:00

Venue: Orchid Room(2F),

GRAND INTERCONTINENTAL SEOUL PARNAS
521 Teheran-ro, Gangnam-gu, Seoul

More info at: http://people-x.com/webmail/ifcc2022/m-e02.html

 53

REGISTRATION
ON-SITE
AFTER 13 JUNE ONLY ON-SITE REGISTRATIONS WILL BE POSSIBLE

Full Registration € 750,00

Young Registration & Technicians (from Korea) € 375,00
Day Registration € 250,00

THE FULL REGISTRATION AND YOUNG REGISTRATION FEES INCLUDE:

1. entrance to plenary lectures, symposia, educational workshops, posters sessions and
exhibition
2. possibility to submit abstracts
3. certificate of attendance
4. coffee and tea service during intermissions
5. Opening Ceremony and Welcome Cocktail (Sunday, 26 June 2022)
6. Closing Ceremony (Thursday, 30 June 2022)

THE DAY REGISTRATION FEE INCLUDES, FOR THE DAY OF

REGISTRATION ONLY:
1. entrance to plenary lectures, symposia, educational workshops, posters sessions and
exhibition
2. certificate of attendance
3. coffee and tea service during intermissions

LIABILITY AND INSURANCE

Registration fees do not include the insurance of participants against personal accidents, sickness
and cancellations by any party, theft, loss or damage to personal possessions. Participants are
advised to take out adequate personal insurance to cover travel, accommodation, cancellation
and personal effects.

REMEMBER TO LOGIN IF YOU REGISTERED FOR HYBRID WORLDLAB

54

CONGRESS VENUE
Coex is a business and cultural hub located in the heart of Gangnam, more are all located at Coex.
Seoul’s business district. It is a popular entertainment destination in Coex is also Korea’s top business events destination. The Coex
Seoul for both domestic and foreign visitors, and welcomes an average Convention and Exhibition Center itself is a four-floor meetings venue
of 150,000 people a day. with over 450,000 m2 of total floor space. There are over 200 exhibitions
Asia’s largest underground mall, three five-star hotels, two premier office and 2,000 conferences here each year.
towers, a department store, a subway station, an airport terminal, and

HOW TO GET TO COEX FROM INCHEON AIRPORT

TAXI SUBWAY LIMO BUS SERVICES: DELUXE #6006

Approximately 60min KRW 4,250 Approximately 75min
KRW 80,000 (standard) Incheon International Airport Station(Incheon KRW 15,000 (Adult, one-way)
KRW 110,000 (deluxe) Airport Railroad) > Gimpo Intl. airport station, Bus stop at Samseong Station Exit 7
transfer to subway line 9 > Bongeunsa Station
LIMO BUS SERVICES: DELUXE #6103
Approximately 120 min Approximately 65min
KRW 15,000 (Adult, one-way)
Incheon International Airport Station(Incheon KRW 2,000 discount for a round-trip ticket
Airport Railroad) > Hongik Univ. Station, Bus stop at City Airport
transfer to subway line 2 > Samseong Station
LIMO BUS SERVICES: DELUXE #6703
Approximately 120 min Approximately 80min
KRW 16,000 (Adult, one-way)
Bus stop at Coex Intercontinental Hotel

COEX
(CONVENTION AND
EXHIBITION CENTER)

513, YEONGDONG-DAERO,
GANGNAM-GU
SEOUL 06164
REPUBLIC OF KOREA

www.coexcenter.com
 55

COEX MAP

3F
2C
2B
2A

AUDITORIUM Auditorium
- Opening Ceremony
- Plenary 1C
- Symposia 1B
1A

AUDITORIUM ROOMS
- APFCB Closed Meetings
- Companies Hospitality Rooms

2F
209A
211
210B - Speakers‘ Preview Room
210A
209B
209A
203 208

206A
202
- KSCC Room
206A
201
206B
206B 207
205B
- COC Office 205A
204

204/205/207/208/
209B/210/211
- IFCC Closed Meetings

1F Rooms 101 - 105

- Symposia
- Educational Workshops
- Lunch Workshops
- APFCB Executive Board Meeting
Hall B
- Exhibition Area
- E-posters Area
- Coffee Breaks

Hall B
105
104

103

102

Lobby 101

- Registration Desks
- Bag Delivery Desk
- Institutional Stands North Gate
56

GENERAL
INFORMATION

REGISTRATION DESK INDUSTRY EXHIBITION

The registration desk, located at the entrance of Hall B, The exhibit of diagnostics companies makes up a very
Level 1, is open as follows: important part of the conference. All major international
26 June 11:00 - 19:00 29 June 08:00 - 18:00 clinical-biochemistry and laboratory-medicine companies
27 June 08:00 - 18:00 30 June 08:30 - 14:00 are represented.
28 June 08:00 - 18:00 Participants are encouraged to visit the large industry
exhibition, which is located in Hall B, Level 0 and open
OFFICIAL LANGUAGE as follows:
The official language of the congress is English. No Monday 27 June 10:00 - 17:30
simultaneous translation is provided. Tuesday 28 June 10:00 - 17:30
Wednesday 29 June 10:00 - 17:30
NAME BADGE
All participants will receive a name badge when they Access to the exhibition area is free of charge and does
check-in at the registration desk. The badge must be not require congress registration. However, for security
worn at all times since only registered participants will be reasons, anyone wishing to visit the exhibition without
admitted to the scientific sessions. It must also be worn registering for the whole conference must report to the
at the social events organised as part of the congress. Visitors Desk, at the entrance of Hall B.

CONGRESS KIT COFFEE POINTS

The congress kit can be collected at the Congress Kit During intermission in the morning, inside the Exhibition
corner, at Level 0, on the left side of the registration desk, Area, Hall B, self-service coffee points offer coffee and
upon presentation of the congress-kit ticket provided tea free of charge for all properly registered delegates.
with your badge.
BARS/RESTAURANTS
SPEAKERS’ PREVIEW ROOM COEX is also one of the biggest shopping centers in
The Speakers’ Preview Room is located in Room 209A, Korea. For your lunch break, eat out on global cuisines
on Level 2. Speakers are kindly requested to bring their and coffees.
presentation to the audiovisual centre on a USB drive
at least two hours before the presentation is scheduled.
Personal laptops cannot be connected to the system.

CERTIFICATE OF ATTENDANCE
All properly registered attendees will receive a certificate
of attendance by e-mail, the week after the conference.

WIRELESS CONNECTION
WorldLab Seoul 2022 is offering free WiFi for delegates
in all Congress Center.
Network: Coex free wifi zone

E-POSTERS
E-Posters are available inside the Exhibition Area, Hall B.
From Monday to Wednesday, from 10:00 to 17:30.

ABSTRACT PUBLICATION
All abstracts are published in a special on-line issue of
Clinica Chimica Acta (CCA).
 57

HANJIN TRAVEL
is the officially appointed Housing Agency for Worldlab Seoul 2022.
For all your private or group hotel reservations, please contact:
Mr Tae Woong Yoon - [email protected]
Phone: +82 2 726 5541

PEOPLE-X, INC.
1F Haeoreum Bldg.,
16, Yeoksam-ro 17-gil,
Gangnam-gu, Seoul 06246 - Korea
Phone: 82-2-566-6031, 82-2-566-6067
Email: [email protected]

CONGRESS SECRETARIAT

MZ Events s.r.l.

Via Carlo Farini 81 - 20159 Milano (Italy)

Phone: +39 02 66802323
Fax: +39 02 6686699
E-mail: [email protected]

www.seoul2022.org
58

PLATINUM
SPONSORS
GC LABS
GC Labs is the South Korea’s leading clinical laboratory, a specialist in infectious diseases, and serves as
part of the Global Diagnostics Network. GC Labs has enabled patients to receive accurate diagnoses and
the right treatment with unrivaled quality of routine and specialized clinical tests. Around 800 employees
at GC Labs offer more than 5,000 tests and test combinations, ranging from routine tests to highly esoteric
molecular and genetic assays. With more than 40 years of accumulated know-how, GC Labs values the
principles of providing the best treatment for patients even in unpredictable medical environments through
passionate and ceaseless efforts. Not only domestically, but GC Labs has managed to expand overseas
by entering a Lab Service Agreement with different areas of the world in Asia, Middle East and etc. GC
Labs is qualified with excellent medical standard of medical manpower, level, infrastructure. Please visit
our official website for further information: www.gclabs.co.kr/eng.
Contact – Sean Hwang [email protected]
Address – 107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si,Gyeonggi-do, Republic of Korea

ROCHE
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines,
Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro
diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare
and want to further transform how healthcare is delivered to have an even greater impact. To provide the
best care for each person we partner with many stakeholders and combine our strengths in Diagnostics
and Pharma with data insights from the clinical practice.
In recognising our endeavor to pursue a long-term perspective in all we do, Roche has been named
one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability
Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to
healthcare together with local partners in every country we work.
Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority
shareholder in Chugai Pharmaceutical, Japan.
For more information, please visit www.roche.com.
Roche Diagnostics International Ltd.
Centralised and Point of Care Solutions
Forrenstrasse 2, 6343 Rotkreuz, Switzerland
www.roche-rotkreuz.com
All trademarks used or mentioned in this release are protected by law.
60

GOLD
SPONSORS
ABBOTT
Abbott is a global leader in in vitro diagnostics with one of the broadest portfolios of businesses spanning
nearly every segment – point of care, immunoassay, clinical chemistry, hematology, blood screening,
molecular, and informatics. Abbott’s life-changing tests and diagnostic tools provide accurate, timely
information to better manage health. We’re empowering smarter medical and economic decision making
to help transform the way people manage their health at all stages of life.
Abbott Laboratories (Singapore) Pte Ltd
3 Fraser Street #23-28, DUO Tower, Singapore 189352
Contact person: Wipa Parapat – Area Brand Manager
Email: [email protected] - Mobile: +6698 2896699
www.abbott.com

BECKMAN COULTER
We are committed to advancing healthcare for every person by applying the power of science, technology
and the passion and creativity of our teams to enhance the diagnostic laboratory’s role in improving
healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in
hospitals, reference laboratories and physician office settings around the globe.
An operating company of Danaher Corporation since 2011, Beckman Coulter is headquartered in Brea,
Calif., and has more than 11,000 global associates working diligently to make the world a healthier place.
Beckman Coulter - 3rd floor, 281 Gwangpyeong-ro, Gangnam-gu, Seoul, Korea 06349, South Korea
Ph. (02) 6420 - 3100 - Fax: (02) 6420 - 3120
www.beckmancoulter.com - [email protected]

SIEMENS HEALTHINEERS
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For
everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany,
Siemens Healthineers and its regional companies is continuously developing its product and service
portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the
next generation of medical technology. These new applications will enhance the company’s foundation
in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens
Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability
to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens
Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion
and adjusted EBIT of €3.1 billion. Further information is available at www.siemens-healthineers.com

SNIBE DIAGNOSTIC
Shenzhen New Industries Biomedical Engineering Co., Ltd (briefed as Snibe) is a leading global in-vitro
diagnostic biomedical company. Snibe has focused on the Chemiluminescent immunoassay (CLIA) field
for more than 27 years. We are providing customized diagnostic solutions to laboratories in more than
147 countries and regions. Over 22000 units of Snibe’s products have been installed in hospitals and labs
worldwide, including global chain labs like Synlab, Eurofins, Cerba, Synevo, etc.
Snibe established 4 core R&D centers, including reagent, instrument, magnetic microbead, and reagent
raw material to lay a solid foundation for developing the broadest range of CLIA analyzers and test menu.
We successfully developed the fastest CLIA analyzer in the world - MAGLUMI X8 with the throughput
of 600T/H in 2018. In order to meet the demand of mega-laboratories, Snibe announced a strategic
partnership with Thermofisher and Hitachi to launch the Total Laboratory Automation solution in 2019.
Moreover, to help the fight against COVID-19, Snibe successfully developed the 2019-nCoV (SARS-
CoV-2) CLIA Kits in 2020, the first of its kind in the world to received CE mark.
Our Mission is “Creating value for human health through continuous innovation”.
[email protected] - www.snibe.com
 61

GOLD
SPONSORS
SYSMEX
Since its foundation, Sysmex has grown by expanding its business model in the in-vitro diagnostics field
and developing its business globally. Our business centers on the in-vitro diagnostics (IVD) field, based
on our mission of “Shaping the Advancement of Healthcare.” It is expressed in the “Sysmex Way,” the
corporate philosophy of the Sysmex Group. We provide high-value-added products and services, aiming
to contribute to a fulfilling and healthy society.
In the IVD field, Sysmex is ranked seventh globally. We have a leading share of the global market in the
hematology field, with a share of more than 50%. Furthermore, in the hemostasis and urinalysis fields, we
formed alliances to expand our portfolio and achieve a high share of the global market. Meanwhile, we
are building a robust installed instrument base in the immunochemistry field, where we are developing our
business, mainly in Asia.
Email: [email protected] - Website: www.sysmex.co.kr
Contact: +82-2-3498-5387 - Fax: 02-3498-5312

SILVER
SPONSOR
SEEGENE MEDICAL FOUNDATION
Seegene Medical Foundation contributes to human health and welfare through accurate testing and
innovative research!
Seegene Medical Foundation is a clinical laboratory in KOREA that provides over 4,000 test services
for clinical practice and research in all fields including routine laboratory tests, molecular diagnosis,
diagnostic pathology service, clinical research to nation-wide hospitals, and clinics.
Seegene Inc. and SG Medical are affliates of Seegene Medical Foundation. Seegene Inc. is the world’s
leading developer of muliplex molecular technologies and multiplex molecular diagnostics(MDx). SG
Medical provides solution in clinical IVD market by concrete partnership with top global companies.
Address: 320, Cheonho-daero, Seongdong-gu, Seoul, 04805, Korea
Telephone: +82-1566-6500 - Fax: +82-2-3394-6503
Website : www.seegenemedical.com - E-mail : [email protected]
 63

BRONZE
SPONSORS
ARKRAY
Day after day, ARKRAY strives to realize our mission “To contribute to the health and well-being of
people all over the world through the advancement of science and the discovery of new technologies” by
providing new diagnostic technologies and tests to the healthcare field.
In addition to the clinical testing devices and reagents for testing collected blood or urine samples, we
currently provide comprehensive support to the medical field ranging from development, manufacturing,
sales and servicing including diagnosis support tools such as software.
Furthermore, in response to diversified medical needs and values in each region and country, ARKRAY
has established a global structure that allows us to swiftly deliver our high value-added products to more
than 80 countries and regions.
Trade Name: ARKRAY, Inc.
Location: 59 Gansuin-cho, Kamigyo-ku, Kyoto 602-0008, JAPAN
TEL: +81-75-662-8979 URL : https://www.arkray.co.jp/english/

BINDING SITE
Binding Site provides specialist diagnostic products to clinicians & laboratory professionals worldwide.
Delivering innovative medical solutions that improve the diagnosis and management of blood cancers &
immune system disorders. We are committed to
improving patient lives worldwide through education, collaboration, and innovation. Visit us on stand 101,
with our local distribution partner, Dow Biomedica, and see how we can help you to maximise your protein
service.
Discover Optilite®, our dedicated special protein system, the latest innovation in special protein analysis,
delivering, fast, high-quality, and reliable results at an impressive throughput.
Learn how Myeloma patients benefit from Freelite® assays, Freelite® is the ONLY serum free light chain
test recommended by International and national guidelines with more than 20 years of clinical evidence.
Address: 8 Calthorpe Road, Birmingham B15 1QT
[email protected] - www.bindingsite.com

HANDOK
The Health Innovator, Handok
Handok is committed to innovation and its business has grown both through strategic partnerships with
other companies as well as through innovative research. Handok was founded in 1954 and has been
listed on the Korea Stock Exchange since 1976. The company has never recorded a deficit year since
establishment.
Handok grew as a joint venture with Hoechst/Aventis/Sanofi from 1964 to 2012. Handok has also established
strategic collaborations in several areas with multiple multinational pharmaceutical companies. Handok
ended its joint venture relationship with Sanofi in 2012 and became an independent company again.
Handok changed its company name from Handok Pharmaceutical Co., Ltd to Handok Inc. and declared its
vision to become “The Health Innovator” and as Korea’s leading global healthcare company.
Handok’s businesses mainly focus on prescription drugs along with consumer health care products,
medical devices and in vitro diagnostics, food supplements and medical nutrition.
Handok Inc.
132, Teheran-ro, Gangnam-gu, Seoul, 06235, Rep. of Korea
Tel +82 2 527 5114 - www.handok.com
64

BRONZE
SPONSORS
A&T
A&T supports medical care and contributes to people’s health around the world. As an Integrated
Solution Provider, A&T works on product development, manufacturing, marketing and customer
support in the all fields of C-A-C-L(Chemicals, Analyzers, Computers, Lab-Logistics).
Address: 10F, Yokohama Plaza Bldg. 2-6 Kinko-cho, Kanagawa-ku, Yokohama,
Kanagawa 221-0056, Japan
Tel. +81-45-440-5813 - http://www.aandt.co.jp/jpn/index.htm

HANLAB
Since 1993, with respect for life and accumulated experiences and know-hows in Laboratory Medicine
fields, Hanlab Corporation has developed and manufactured laboratory automation system and provided
with analyzers, reagents, software, lab environment motioning system and related services.
Hanlab is a professional company in the field of laboratory automation, having created the first auto-
balancing centrifuge system in the world. Although it had been a continuation of hardships and difficult
challenges, the accumulation of our own technologies propels us to develop the laboratory automation
systems for actualization of the SMART Lab.
Address: 8, Osongsaengmyeong 5-ro, Osong-eup, Heungdeok-gu, Cheongju-si,
Chungcheongbuk-do, Korea (28161)
Tel. +81-45-440-5813 - HP: http://www.aandt.co.jp/jpn/index.htm

ORTHO CLINICAL DIAGNOSTICS

Ortho Clinical Diagnostics is one of the world’s largest pure-play in vitro diagnostics (IVD) companies
dedicated to transforming patient care. More than 800,000 patients across the world are impacted by
Ortho’s tests each day. Because Every Test Is A Life™, Ortho provides hospitals, hospital networks,
clinical laboratories and blood banks around the world with innovative technology and tools to ensure test
results are fast, accurate and reliable. Ortho’s customized solutions enhance clinical outcomes, improve
efficiency, overcome lab staffing challenges and reduce costs.
Website: www.orthoclinicaldiagnostics.com

SCL
SCL(Seoul Clinical Laboratories), a clinical diagnostic laboratory founded in 1983, is the first referral
laboratory in Korea to receive accreditation from the CAP(College of American Pathologists). Our expertise
and reliability as an inspection agency of CAP, world-class quality assurance institution have been certified
since 1998. In addition, we are continuously improving the quality of laboratory by participating in various
international and domestic prominent external quality assurance programs.
By endeavoring to fulfill its core values, ‘Responsibility, Professionalism, Communication and Innovation’,
SCL has developed into the largest nationwide laboratory with the best reputation in the reference
laboratory field in Korea. SCL provides a wide variety of specialized laboratory assays and cutting edge
research tests to over 4,500 medical institutions nationwide. SCL intends to increase its presence as
the world class reference laboratory by providing precise test results and high quality customer-oriented
services to medical practitioners throughout the world, as well as throughout Korea.
Address :13, Heungdeok 1-ro, Giheung-gu, Yongin-si, Gyeonggi-do, Korea
Telephone: +82-1800-0119 - Website: www.scllab.co.kr
 65

BRONZE
SPONSORS
SEBIA
Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable
and interpretable language.
We call it our new language of life. It makes it easier to understand, diagnose and treat chronic and
metabolic diseases. Cancer, obesity, aging and depression share a common biology: they are metabolic
and inflammatory. Those pathological imbalances lead to protein modification which require special
separation techniques to give us a better understanding. Capillary Electrophoresis (CE) is the most
accurate and efficient method of separation to unlock these complex conditions.
Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents for the
screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma),
Diabetes, Hemoglobinopathy and other rare pathologies.
This year Sebia is going direct in South Korea with the opening of its new subsidiary.
27 rue Léonard de Vinci - 91090 Lisses, FRANCE
+33 (0)1 69 89 80 80 - www.sebia.com

SEKISUI DIAGNOSTICS
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping
improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories.
We continue to invest in the areas of diabetes, infectious disease, diagnostic enzymes and automated
systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation
systems in Japan.
Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in
Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents.
We develop, manufacture, and supply billions of tests each year to the global healthcare market through
our commercial networks and partners. Our product lines include:
• Clinical chemistry reagents
• Point-of-care rapid tests
• Enzymes and specialty biochemicals
www.sekisuidiagnostics.com - [email protected]

THERMO FISHER SCIENTIFIC

ThermoFisher Scientific instruments, equipment, software, services and consumables empower scientists
to solve for complex analytical challenges in pharmaceutical, biotechnology, academic, government,
environmental and industrial research, as well as the clinical laboratory. Our products address a range of
needs from sample, material characterization and chemical analysis to clinical diagnoses and biological-
based therapeutics manufacturing.
Thermo Fisher Scientific, 168 Third Avenue, Waltham, MA USA 02451 - Tel: 781-622-1000
10~12F, Suseo Office Bldg., 281 Gwangpyeong-ro, Gangnam-gu, Seoul 06349, South Korea
Tel: 82) 1661-9555 - www.thermofisher.com
 67

EXHIBITORS

ARK DIAGNOSTICS
ARK Diagnostics Inc. develops, manufactures, and distributes in vitro diagnostic immunoassays for Therapeutic Drug
Monitoring (TDM) and Urine Drug Testing (UDT). For TDM, clinicians use these measurements to guide dosing decisions
for safe, effective, and personalized drug therapy. By optimizing drug levels, clinicians improve outcomes, reduce toxicity,
and lower healthcare costs. For UDT, ARK has several unique assays for Fentanyl II, Pregabalin II, Gabapentin, and
Methylphenidate Metabolite. Additionally, ARK has many other unique TDM and UDT Assays.
ARK’s quality management system is certified to ISO 13485:2003. The company is committed to quality compliance
and carefully follows Good Manufacturing Practices. ARK uses its unique blend of scientific expertise and deep industry
knowledge to deliver high-quality assays for new generations of drugs. Its highly regarded homogeneous enzyme
immunoassay technology is adaptable to a variety of clinical chemistry analyzers.
ARK Diagnostics, Inc., 48089 Fremont Blvd, Fremont, CA USA 94538; www.ark-tdm.com; [email protected]

BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving
medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and
solutions that help advance both clinical therapy for patients and clinical process for health care providers.
BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety
and efficiency of clinician’s care delivery process, enable laboratory scientists to better diagnose disease and advance
researcher’s capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually
every country and partners with organizations around the world to address some of the most challenging global health
issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to
health care.
Headquarters: 1 Becton Drive Franklin Lakes, NJ 07417-1880 - USA - Ph.: 201.847.6800 - [email protected]
BD Korea: 16F Arc Place Bldg.142, Teheran-ro, Gangnam-gu, Seoul, 06236, Korea - Ph.: 82.02.3404.3700
[email protected] - www.bd.com

BOM MEDICAL
BOMMEDICAL is the pioneering company in the diagnostic test market with its distribution biotechnology and in vitro
diagnostic products. Since its establishment in 2000, BOMMEDICAL has led innovations in the production of Cardiac,
Liver, and Diabetes markers. With the highest standards of integrity, we carry out our business and service our customers’
commitment to improving patient care quality. We dedicate our efforts to providing the top quality products to our customers.
We promise to continue achieving beyond our successes and position ourselves to be the best healthcare company in the
world.
A-3F, 11, Beobwon-ro 11gil, Songpa-gu, Seoul, Korea
Tel. 82-2-477-5916 - Fax. 82-2-477-5917

BÜHLMANN LABORATORIES
BÜHLMANN is the established provider for excellence in reliable quantitative fecal analysis of calprotectin and pancreatic
elastase. The clinical value is proven in over 100 peer reviewed publications.
BÜHLMANN offers rapid and easy lateral flow analysis in inflammatory diseases with Quantum Blue® calprotectin, infliximab
and adalimumab testing for immediate therapy adaptation options.
The BÜHLMANN fCAL® turbo assay is the consequent continuation of this success and is applicable on most clinical
chemistry platforms allowing random access and fulfils today’s requirements for automation and streamlining of the workflow
in a modern lab environment.The unique CALEX® stool extraction device provides the quality needed for quantitative fecal
analysis; its ease of use eliminates direct contact with stool. The design and the consequent separation of pre-analytics
and analytics allows lay persons to collect the sample and lab staff only needs loading the sample onto laboratory tracking
systems.
BÜHLMANN Laboratories AG, Baselstrasse 55, CH-4124 Schönenbuch
Phone +41 614871212 - Fax +41 614871234 - Email: [email protected] - Web: www.buhlmannlabs.ch
68

COLLEGE OF AMERICAN PATHOLOGISTS

As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and
external quality assessment/proficiency testing (EQA/PT) programs, the College of American Pathologists (CAP) serves
patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory
medicine worldwide. The CAP’s EQA/PT program offers a comprehensive range of programs that constantly evolve to keep
laboratories in step with these changes to have more time for what matters most—accuracy in the laboratory. From routine
to esoteric, our programs help laboratories deliver performance they can measure and accuracy they can trust. For more
information on our EQA/PT, visit cap.org. Also, learn more about the CAP: CAP Annual Report.
Wendy Johnson: [email protected]
325 Waukegan Road, Northfield, IL 60093 USA

DAKLAPACK
DaklaPack is an innovative and international organization with our origins in the packaging industry. In our medical
department, we supply shipping packaging to hospitals and laboratories around the world on a daily basis, which is used to
package diagnostic material. We focus on making our products as user-friendly as possible while also taking into account
environmental friendliness.
In addition, our service goes further and we compile sample sets for an increasing number of parties, allowing them to
provide their customers with a simple and user-friendly sample collection.
DaklaPack Europe B.V.
Kamerlingh Onneslaan 6, 8218 MA LELYSTAD, The Netherlands
T: +31 (0) 320 277 900 - W: https://www.daklapack.com/

EONE LABORATORIES
EONE Laboratories is one of leading diagnostic laboratory in South Korea. Started as a specialized radioimmunoassay
laboratory in 1983, Eone laboratories has grown as a result of consistent efforts in adopting innovative techniques and
quality control. With experienced specialists in laboratory medicine, pathologists, clinical scientists, and medical laboratory
technicians, we are committed to providing informations and services to assure that correct tests are performed to make the
right diagnostic decision. In 2013, we expanded our business in Songdo International Business District, which enables us
to provide nation’s largest scale laboratory testing services with state-of-the-art laboratory facility. We offer broad access
to clinical testing services through our national networks.
(22014) 291, Harmony-ro, yeonsu-gu, Incheon, KOREA
TEL. 1600-0021 FAX. 032-210-2233 [email protected]

EUROIMMUN
EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy and molecular
genetic diagnostics. The company’s portfolio encompasses indirect immunofluorescence assays (IFA), ELISAs,
immunoblots, radioimmunoassays, chemiluminescence immunoassays (ChLIA) and molecular genetic test systems and
spans over a thousand diagnostic parameters. State-of-the-art instruments and software provide efficient automation
of analyses, increasing productivity and reliability in routine diagnostics. EUROIMMUN commands extensive know-how
and a broad technology base allowing inhouse research, development and production to optimally meet the customer
needs. Laboratories in over 140 countries rely on our test systems as well as automation and software solutions.
Pioneering developments include BIOCHIP technology, designer antigens, recombinant-cell IFT and computer-aided
immunofluorescence microscopy. Latest innovations include the EUROPattern Microscope Live with EUROLabOffice 4.0
software for ultrafast automated microscopy incorporating image classification using artificial intelligence.
Seekamp 31, 23560 Luebeck, Germany
Contact person: Nina Wehrhoff - [email protected]
 69

EUROSPITAL
Eurospital focuses its activities in specific sectors such as in vitro diagnosis of autoimmune disorders, coeliac disease, IBD,
as well as detection of genetic predisposition to develop coeliac disease, type 1 diabetes and lactose intolerance.
Actively present worldwide, Eurospital aim is to provide paediatricians, gastroenterologists and laboratory immunologists
with highly innovative products for different technologies such as ELISA, turbidimetric, lateral flow and RT-qPCR for
antibodies detection, calprotectin determination, coeliacs definition and genetic predisposition determination.
www.eurospital.com/en/business-units/diagnostic-area/
Eurospital S.p.A.
Via Flavia 122, 34147 Trieste, Italia - Phone number: +39 04089971 - E-mail: [email protected]

EXIAS MEDICAL
EXIAS Medical is a company located in Graz, Austria that is developing analyzers in the point-of-care and laboratory
field since 2014 and has been growing continuously. Our long-term experience combined with the spirit of an ambitious
and dynamic company, is more than beneficial to address the needs of healthcare professionals worldwide. As a distinct
manufacturer of measurement systems and accessories, we set new standards through performance, usability and high-
quality. In addition, we operate as an OEM partner for providers in the field of clinical chemistry.
EXIAS Medical GmbH : Kratkystraße 2, 8020 Graz, Austria
[email protected] - www.exias-medical.com

GENESYSTEM
Genesystem is a biotech engineering company specializing in molecular testing solutions to target on-site testing needs. We
develop and market state-of-the-art PCR platforms, related reagents and biochip products which are designed to enhance
the health of human societies and the quality of human life. The application fields we target include clinical diagnostics, food
testing and veterinary diagnostics where we have been implementing successful partnerships with global partners. Ongoing
R&D efforts of Genesystem in accordance with its future-oriented business milestone will lead to the launch of variety of
innovative products Including GENECHECKER® series of PCR platforms, SMARTCHEK® molecular testing assays and
MultiCHEK®multiplex biochip products. We assure our clients that our engineering expertise and know-how would create
greater values for our client’s applications. We are taking big strides to achieve our goal and vision for becoming a global
leader for point-of-care molecular testing markets and contributing to societies for a better world.
Tel. +82 429391086 - Mobile. +82 1050499222
E-mail. [email protected] / [email protected]
Address. 200-9, Techno 2-ro, Yuseong-gu, Daejeon, 34028, Republic of Korea

GREINER BIO-ONE
Greiner Bio-One specializes in the development, production and distribution of high-quality plastic laboratory products.
The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic,
pharmaceutical and biotechnology industries. Greiner Bio-One is split into three divisions - Preanalytics, BioScience and
Sterilization. As an Original Equipment Manufacturer (OEM), Greiner Bio-One provides individual solutions in the area of
custom-made design developments and production processes for the life sciences and medical sectors.
In 2020, Greiner Bio-One International GmbH generated a turnover of 695 million euros and had 2,540 employees, 28
subsidiaries and numerous distribution partners in over 100 countries. Greiner Bio-One is part of Greiner AG, which is
based in Kremsmünster (Austria).
Bad Haller Strasse 32 - 4550 Kremsmuenster, Austria - [email protected] - +43 75836791-0

HUVAROS
Huvaros (www.huvaros.com) markets the online web application MA Generator.
The MA Generator tool allows laboratories to perform error detection simulations on their own laboratory specific datasets.
This enables them to optimize and validate moving average QC or Patient-Based Real-Time QC (PBRTQC) settings. The
obtained settings can then be programmed on software available at the lab (analyzer, middleware, LIS) to use moving
average QC or (PBRTQC) real-time in routine clinical practice. Also the settings are valuable to design and validate the
overall QA/QC plan of a test. In a similar way the MA Generator can be used to optimize and validate auto-verification
settings of limit checks. Huvaros was founded in 2015 by Huub van Rossum and is located in The Netherlands.
Contact: [email protected]. When interested in a MA Generator Demonstration, contact [email protected]
70

IMPROVE MEDICAL
IMPROVE MEDICAL was founded in 1996, a national high-tech enterprice who has been focusing on pre-analytiacl
variation control of specimen for 26 years. IMPROVE MEDICAL has grown to be the top supplier of venous blood collection
sepecimen in China and becomes one of the leading suppliers in wordwide. Now IMPROVE group has 20 subsidiaries home
and abroad, our products and service including: Precision Medicine, intelligent medical service and medical service. Our
vacuum tubes Gel & Clot Activated Tube is the uniqe US FDA 501(K) approved in China. And we are the first batch IVDR
acquried company for evacuated blood collect tubes in wordwild. We provide products, technologies, services and solutions
to almost 100 countries and areas all of the world.
Address: No. 102, Kaiyuan Avenue, Science City, Guangzhou Economic & Technological Development District,
Guangzhou,China - Phone: +86-20-32312610/1/2/3/4/5/6/7 - Fax: +86-20-32312667/2611
Email: [email protected] - [email protected] - [email protected]

LABQUALITY
Labquality is an independent Finnish external quality assessment provider with over 50 years of experience in helping
clinical laboratories develop and maintain their performance. Over 7,500 medical laboratories and point-of-care testing
sites all over the world have chosen Labquality as their primary EQA provider because of the clinically relevant design of
our EQA programs and the professional support of our local partners. Our main EQA schemes are accredited according
to ISO 17043 (PT02/FINAS). In addition, Labquality’s consultation team of experts serves medical device manufacturers
by providing comprehensive consulting services for, among other things, global product registration. Our experts all have
more than 15 years of experience in the registration, quality, and product development of medical devices. We have made
hundreds of registrations in the EU and over 40 other countries. We are looking for distributors!
Juha Wahlstedt: [email protected] - +358 50 3275338 - www.labquality.fi
Labquality Oy, Kumpulantie 15, 00520 Helsinki, Finland

LG CHEM, LTD.
LG Chem helps the people to lead a healthy life by strengthening its R&D competence in Life Sciences. Life Sciences is the
company’s new growth engine in the mid to long term goal. The company has secured the differentiated R&D competence
and has received the U.S. FDA approval for its new drugs for the first time in Korea. LG Chem’s Diagnostics division has
been accomplished remarkable success in Korean Market. LG Chem is supplying HCV, HIV test to Korea National Blood
Bank from 1998 and has strong market leadership in allergy screening and molecular diagnostics of infectious diseases.
LG Science Park E14, 70, Magokjungang 10-ro, Gangseo-gu, Seoul, Republic of Korea
Tel: +82 2 6987 4213 / Email: [email protected] - Website: www.lgchem.com

NOVA BIOMEDICAL
Nova Biomedical is a world leader in point of care and critical care whole blood in vitro diagnostic testing. Its products are
marketed in six worldwide market areas—Hospital, Clinic/physician Office, A&E, Veterinary, Blood Bank, and Self-test.
Hospital and veterinary products include StatStrip® hospital point-of-care meters for interference-free glucose testing,
creatinine and eGFR testing for rapid renal function monitoring, lactate testing to monitor tissue perfusion, and Hb &
Hct testing for rapid anemia assessment. Nova’s Stat Profile® critical care blood gas analyzers feature no-maintenance
cartridges, MicroSensor card technology, and a 22-test menu including iMg, Urea, Creatinine, estimated plasma volume
(ePV) and Cooximetry with results in about a minute. Allegro™ for physician office labs is a fast, simple, capillary blood
analyzer providing HbA1c, lipids, urine creatinine/albumin, PT/INR, and CRP with results available during a patient visit.
EMS Stat™ is a portable system for ambulance and emergency use for rapid glucose, ketone, lactate, hemoglobin, and
hematocrit testing using tiny capillary blood samples.
Nova Biomedical
200 Prospect Street - Waltham, Massachusetts 02454 USA
Tel. 781-894-0800 - Fax. 781-894-5915
Email. [email protected] - Web site. www.novabiomedical.com
 71

QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that
enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample
technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make
these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report
relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN
provides solutions to more than 500,000 customers around the world in molecular diagnostics (human healthcare), Applied
Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). Further
information can be found at https://www.qiagen.com/.
QIAGEN Korea Ltd.
5th Fl., Seoul Square 416, Hangang-daero, Jung-Gu, Seoul, Korea
Orders: 080-000-7146 - Technical: 080-000-7145

QUIDEL CORPORATION
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid
testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years
in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the
firs to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names, Sofia®, Solana®, Lyra®, Triage®
and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of 8 infectious diseases, cardiac
and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s
mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our
families, our communities and the world.
Quidel
9975 Summers Ridge Road - San Diego, CA 92121
www.quidel.com

RADIOMETER
Radiometer provides powerful acute care diagnostic solutions based on a belief that a seamless relationship between
people and technology is crucial. Since developing the world’s first commercially available blood gas analyzer in 1954, we
have continuously advanced our acute care diagnostic solutions with dedication, clinical evidence, attention to detail, and
heartfelt passion. Together we bring reliable, connected solutions to critical care settings around the world.
The innovation and improvement of our products and solutions come from the passion and persistence of our associates.
We believe that great ideas and results come from associates who are inspired to grow. Our diverse community of
colleagues, work and collaborate with health care professionals and hospitals around the world to continuously improve the
diagnostic experience and patient outcomes. We promise that whatever comes next, we make sure life comes first.
Radiometer Korea
Eunsung Bldg. 15Fl., 741 Yeongdong-daero, Gangman-gu, Seoul, Korea
Tel: 02) 2056 9300 - E-mail: [email protected]

SAMKWANG MEDICAL LAB

Samkwang Medical Lab is a certified diagnostic lab with CAP and ISO9001 with 37 years of history supporting healthcare
providers. As a leading provider of laboratory testing in Korea, SML has established two centers in major regions: Busan
and Daejeon, along with the main center in Seoul. We provide high-quality service through automated laboratory systems
and offer more than 4,000 diagnostic tests, ranging from routine biological tests to specialized genetic tests and so forth.
Also, SML was reorganized to “SamKwang Biotree Group” in 2020, combining with subsidiary companies involved in
biological and medical fields. We will continue to lead the industry with healthcare innovations that provide better health
and service in the diagnostic field.
SAMKWANG MEDICAL LAB
57, Baumoe-ro-41-gil, Seocho-gu, Seoul, 06742, Korea
Tel.: +82-1661-5117 - Fax: +82-2-3497-5249
E-mail: [email protected] - www.smlab.co.kr
72

SD BIOSENSOR
SD Biosensor is a company specializing in point-of-care testing. It is a total solution provider in the in-vitro diagnostics
(IVD) industry, meaning not only does it sell on-site diagnostic reagents and equipment that diagnoses diseases with simple
methods in the field, but also takes the responsibility for developing and manufacturing them. SD Biosensor has established
a full line-up portfolio, extending from screen tests to confirmation tests, which account for about 70% of the global IVD
market. Since the outbreak of COVID-19, the company has developed more than 20 COVID-19 reagent-kits, of which the
COVID-19 Ag Test was the first in the world to obtain WHO Emergency Use Listing. Moreover, SD Biosensor has been
successfully selling M10, the on-site molecular diagnostic platform, after its launch in August, 2021.
SD BIOSENSOR Head Office
C-4&5 Floor, 16, Deogyeong-daero 1556beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16690, REPUBLIC of KOREA
Tel.:+82-31-300-0400 - https://www.sdbiosensor.com/ - [email protected]

WEQAS
Weqas are a Global Provider of Quality in Diagnostic Medicine. Weqas is one of the leading External Quality Assessment
(EQA) providers with over 50 years’ experience in Quality Assurance, providing solutions in Laboratory Medicine. Weqas
provides over 50 EQA Programmes, including external audit, performance analysis and an educational advisory service.
Weqas have an expert team of scientists delivering services in Laboratory EQA, Point of Care (PoCT) EQA, Reference
Measurement Services, Internal Quality Control (IQC), Quality Control Reference Material (QCRM) and Education &
Training.
Benefits of working with Weqas:
1. Accredited to ISO 17043, 17025 and 15195.
2. Over 50 EQA programmes.
3. Access to participant website to monitor instrument performance.
4. Reference Measurement Service for traceability.
5. CE marked IQC and QCRM.
Weqas
Unit 6, Parc T Glas, Llanishen, Cardiff, United Kingdom, CF14 5DU
Ph.: +44 (0)29 20 314750 - Email: [email protected] - https://www.weqas.com

WERFEN
Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain.
We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics and
Autoimmunity. Through our Original Equipment Manufacturing (OEM) business line, we research, develop and
manufacture customized assays and biomaterials.
We operate directly in 30 countries, and in more than 100 territories through distributors. Our Headquarters and
Technology Centers are located in the US and Europe. Worldwide sales exceed $2 billion annually, and our workforce is
more than 5,000 strong.
WERFEN
#1101 Hi-Brand B/D(Living Kwan), Maeheon-ro 16, Seocho-gu, Seoul, 06771, Korea
Tel: 02-1899-9217
E-mail: [email protected]
 25TH INTERNATIONAL CONGRESS OF CLINICAL
CHEMISTRY AND LABORATORY MEDICINE

25TH EUROPEAN CONGRESS OF CLINICAL

CHEMISTRY AND LABORATORY MEDICINE

55TH CONGRESS OF THE ITALIAN SOCIETY OF CLINICAL

BIOCHEMISTRY AND CLINICAL MOLECULAR BIOLOGY

ORGANISING SECRETARIAT
Via Carlo Farini 81 - 20159 Milano (Italy)
Phone: +39 02 66802323
E-mail: [email protected]
74

EXHIBITION AREA MAP

HALL B

Coffee Break
E-POSTER Coffee Break

155 154 134 148 261

138
128 133 136 137 139 141 260

123 119
94 97 101 103 105 108
96

Exhibition 91 89 87
Information 68 72
Table 65 259

258
33 257

6 9 12 14

1 254

Registration Desk IFCC KSCC APFCB

 75

EXHIBITORS LIST

COMPANY POSITION

ABBOTT 14
ARK DIAGNOSTICS 154
ARKRAY 108
BD 259
BECKMAN COULTER 68
BINDING SITE 101
BOM MEDICAL 139
BÜHLMANN LABORATORIES 137
COLLEGE OF AMERICAN PATHOLOGISTS 96
EONE LABORATORIES 134
EUROIMMUN 261
EUROSPITAL 141
EXIAS MEDICAL 91
GC LABS 9
GENESYSTEM 258
GREINER BIO-ONE 87
HANDOK 103
HANLAB / A&T CORPORATION 254
IMPROVE MEDICAL 133
LABQUALITY 119
LG CHEM 128
NOVA BIOMEDICAL 136
ORTHO CLINICAL DIAGNOSTICS 94
QIAGEN 148
QUIDEL 89
RADIOMETER 155
ROCHE 6
SAMKWANG MEDICAL LAB 123
SCL 65
SD BIOSENSOR 138
SEBIA 72
SEEGENE MEDICAL FOUNDATION 105
SIEMENS HEALTHINEERS 12
SNIBE DIAGNOSTIC 1
SYSMEX 33
THERMO FISHER SCIENTIFIC 97
WEQAS 257
WERFEN 260
76

PLATINUM SPONSORS

GOLD SPONSORS

SILVER SPONSORS

BRONZE SPONSORS
 www.dubai2024.org

25th International Congress

of Clinical Chemistry and
Laboratory Medicine

17th Congress of Arab Federation

of Clinical Biology

10th Saudi Society for Clinical

Chemistry Annual Meeting

Venue
Dubai World
Trade Centre
(WTC)

DEADLINES
15 January 2024
Deadline for poster abstract submission

31 March 2024
Deadline for reduced registration fees

Organizing Secretariat
[email protected]
 Creating the
Innovation based future of labs
on your needs WHERE CARE LEADS
IFCC WorldLab Seoul 2022